<?xml version="1.0" encoding="UTF-8"?>
<svg height="777.49" width="545.19" xmlns="http://www.w3.org/2000/svg">
 <g id="page" xmlns:svgx="http://www.xml-cml.org/schema/svgx">
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:1.0;" d="M49.610 53.720 L532.910 53.720 "/>
  <g begin="text">
   <text y="49.34" x="49.606,54.606,59.606,64.606" svgx:width="0.5,0.5,0.5,0.28" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;">494 </text>
   <text y="49.34" x="438.646,443.126,447.606,451.146,453.956,458.336,461.466,464.246,468.826,473.206,476.746,480.286,482.166,486.646,491.336,494.116,499.326,501.306,504.086,509.296,514.506,517.286,520.206,524.786,529.996" svgx:width="0.45,0.45,0.35,0.28,0.44,0.31,0.28,0.46,0.44,0.35,0.35,0.19,0.45,0.47,0.28,0.52,0.2,0.28,0.52,0.52,0.28,0.29,0.46,0.52,0.29" style="fill:rgb(0,0,0);font-family:GillSansStd-Italic;font-size:10.0px;stroke:none;">Poster session 2, 20 (s1)</text>
  </g>
  <g begin="text">
   <text y="767.49" x="49.606,57.736,62.426,64.306,67.116,68.996,73.896,75.776,80.156,82.936,87.516,91.366,93.246,97.626,100.756,105.236,108.776,110.656,114.196,116.976,119.376,123.856,128.546,131.676,136.366,141.056" svgx:width="0.81,0.47,0.19,0.28,0.19,0.49,0.19,0.44,0.28,0.46,0.38,0.19,0.44,0.31,0.45,0.35,0.19,0.35,0.28,0.24,0.45,0.47,0.31,0.47,0.47,0.19" style="fill:rgb(0,0,0);font-family:GillSansStd-Italic;font-size:10.0px;stroke:none;">Multiple Sclerosis Journal</text>
   <text y="767.49" x="142.936,145.716,150.716,155.716,160.716,165.716,167.906,170.686,175.686,180.686,182.876,185.656,188.886,193.466,198.466,201.696,204.476,209.476,214.476,219.476,224.476,229.476,234.476" svgx:width="0.28,0.5,0.5,0.5,0.5,0.22,0.28,0.5,0.5,0.22,0.28,0.32,0.46,0.5,0.32,0.28,0.5,0.5,0.5,0.5,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;"> 2014; 20: (S1) 285–496</text>
  </g>
  <g begin="text">
   <text y="767.42" x="466.181,473.891,477.741,479.931,482.121,485.971,490.241,494.511,499.301,504.301,509.301,514.201,516.391,520.771,526.291" svgx:width="0.77,0.38,0.22,0.22,0.38,0.43,0.43,0.48,0.5,0.5,0.5,0.22,0.44,0.55,0.77" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;">msj.sagepub.com</text>
  </g>
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:0.25;" d="M49.610 226.300 L84.850 226.300 "/>
  <g begin="text">
   <text y="77.103" x="49.606,52.108,56.608,60.604,63.601,67.597,71.593,75.094,79.09,83.59,85.84,87.172,90.169,93.166,97.666,104.668,106.918,108.25,112.75,116.746,120.247,124.243,126.745,129.247,133.747,137.743,139.993,142.243,143.413,148.912,153.412,157.408,160.405,164.401,166.651,167.983,174.481,178.477,181.474,185.47,187.72,189.052,193.552,198.052,200.302,201.634,205.63,210.13,214.126,218.626,223.126,227.122,230.623,232.873,234.205,237.202,241.198,245.698,249.694,252.691,257.191,259.693,264.193,268.693,270.943,272.275,275.272,278.269,282.265" svgx:width="0.28,0.5,0.44,0.33,0.44,0.44,0.39,0.44,0.5,0.25,0.55,0.33,0.33,0.5,0.78,0.25,0.55,0.5,0.44,0.39,0.44,0.28,0.28,0.5,0.44,0.25,0.25,0.55,0.61,0.5,0.44,0.33,0.44,0.25,0.55,0.72,0.44,0.33,0.44,0.25,0.55,0.5,0.5,0.25,0.55,0.44,0.5,0.44,0.5,0.5,0.44,0.39,0.25,0.55,0.33,0.44,0.5,0.44,0.33,0.5,0.28,0.5,0.5,0.25,0.55,0.33,0.33,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">increased from baseline. There were no changes regarding fre-</text>
   <text y="88.101" x="49.606,54.106,58.606,62.602,67.102,71.098,75.598,78.316,82.816,85.813,88.531,95.533,100.033,104.533,109.033,113.029,117.529,120.031,124.027,127.528,129.778,132.496,135.997,138.499,142.495,146.995,153.493,159.496,162.214,166.21,170.71,175.21,177.928,183.931,190.429,194.929,200.005,206.503,212.506,214.756,217.474,223.972,228.472,230.974,235.474,238.192,244.195,250.693,256.696,263.194,267.694,272.77,279.268,285.271" svgx:width="0.5,0.5,0.44,0.5,0.44,0.5,0.25,0.5,0.33,0.25,0.78,0.5,0.5,0.5,0.44,0.5,0.28,0.44,0.39,0.25,0.25,0.39,0.28,0.44,0.5,0.72,0.67,0.25,0.44,0.5,0.5,0.25,0.67,0.72,0.5,0.56,0.72,0.67,0.25,0.25,0.72,0.5,0.28,0.5,0.25,0.67,0.72,0.67,0.72,0.5,0.56,0.72,0.67,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">quency of monocytes, slanDC and CD1+DC. Only BDCA2+DC </text>
   <text y="99.099" x="49.606,54.106,58.102,62.098,65.095,69.091,73.087,76.588,80.584,85.084,87.334,91.33,94.327,96.829,100.825,103.822,106.072,110.068,112.57,116.566,123.568,126.07,130.57,134.566,139.066,146.068,150.064,154.564" svgx:width="0.5,0.44,0.44,0.33,0.44,0.44,0.39,0.44,0.5,0.25,0.44,0.33,0.28,0.44,0.33,0.25,0.44,0.28,0.44,0.78,0.28,0.5,0.44,0.5,0.78,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">decreased after alemtuzumab.</text>
   <text y="110.097" x="49.606,56.104,60.604,65.608,69.604,72.106,77.11,80.611,83.113,87.613,92.617,96.118,99.115" svgx:width="0.72,0.5,0.56,0.44,0.28,0.56,0.39,0.28,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Conclusions: </text>
   <text y="110.097" x="100.969,107.467,109.969,113.965,120.967,123.469,127.969,131.965,136.465,143.467,147.463,151.963,153.817,156.319,160.315,164.311,168.811,170.665,173.167,177.667,179.521,183.517,188.017,189.871,193.867,196.702,199.699,203.695,207.691,210.193,212.695,217.195,221.191,223.045,227.545,231.541,236.041,238.543,242.539,245.041,247.543,252.043,256.543,258.397,262.897,265.894,267.748,274.75,279.25,282.751,285.253" svgx:width="0.72,0.28,0.44,0.78,0.28,0.5,0.44,0.5,0.78,0.44,0.5,0.25,0.28,0.44,0.44,0.5,0.25,0.28,0.5,0.25,0.44,0.5,0.25,0.44,0.33,0.33,0.44,0.44,0.28,0.28,0.5,0.44,0.25,0.5,0.44,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.78,0.5,0.39,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Alemtuzumab lead to an effective depletion of most </text>
   <text y="121.095" x="49.606,54.106,58.606,61.108,63.556,68.056,72.556,75.058,77.506,81.502,84.004,86.506,88.954,91.456,95.956,100.456,104.452,107.953,110.455,112.957,117.457,121.453,123.955,127.951,132.451,134.899,137.401,144.403,151.405,155.905,160.405,164.401,166.849,170.845,174.841,177.343,179.845,182.293,185.794,190.294,194.794,197.296,201.796,206.296,210.292,213.793,216.043,218.491,224.989,227.491,230.326,233.323,237.319,240.316,244.312,248.812,251.314,253.762,256.759,260.755,264.751,269.251,273.751,277.252,279.754,282.256" svgx:width="0.5,0.5,0.28,0.25,0.5,0.5,0.28,0.25,0.44,0.28,0.28,0.25,0.28,0.5,0.5,0.44,0.39,0.28,0.28,0.5,0.44,0.28,0.44,0.5,0.25,0.28,0.78,0.78,0.5,0.5,0.44,0.25,0.44,0.44,0.28,0.28,0.25,0.39,0.5,0.5,0.28,0.5,0.5,0.44,0.39,0.25,0.25,0.72,0.28,0.33,0.33,0.44,0.33,0.44,0.5,0.28,0.25,0.33,0.44,0.44,0.5,0.5,0.39,0.28,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">but not all investigated immune cell subtypes. Different reconsti-</text>
   <text y="132.093" x="49.606,52.108,56.608,59.11,61.612,66.112,70.612,72.862,74.5,79.0,82.996,85.498,88.0,91.996,94.993,99.493,102.994,105.244,106.873,110.869,115.369,119.869,122.119,123.748,129.751,136.249,140.749,145.249,148.246,152.746,156.742,160.243,164.239,166.741,169.243,173.743,177.739,179.989,181.618,185.614,190.114,194.614,197.611,201.607,205.108,208.609,211.111,215.611,220.111,222.361,223.99,230.992,234.988,239.488,241.738,243.376,247.876,250.873,254.869,259.369,261.871,265.867,268.369,270.619,272.248,276.244,280.744,285.244" svgx:width="0.28,0.5,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.33,0.5,0.39,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.67,0.72,0.5,0.5,0.33,0.5,0.44,0.39,0.44,0.28,0.28,0.5,0.44,0.25,0.55,0.44,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.25,0.55,0.78,0.44,0.5,0.25,0.55,0.5,0.33,0.44,0.5,0.28,0.44,0.28,0.25,0.55,0.44,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">tution patterns and CD52-baseline expression may predict and </text>
   <text y="143.091" x="49.606,53.602,57.598,61.594,66.094,70.594,75.094,77.596,79.846,82.456,85.453,89.953,92.95,95.2,97.81,100.312,104.812,109.312,111.814,116.314,118.816,123.316,127.816,131.812,134.314,136.564,139.174,143.17,147.166,149.668,152.17,154.42,157.03,161.53,165.526,170.026,172.528,176.524,179.026,181.528,186.028,190.528,192.778,195.388,199.384,203.884,208.384,210.634,213.244,215.746,222.748,229.75,234.25,238.75,243.25,246.751,251.251,255.751,260.251,263.248,267.244,270.745,274.246,276.748,281.248,285.244" svgx:width="0.44,0.44,0.44,0.5,0.5,0.5,0.28,0.25,0.55,0.33,0.5,0.33,0.25,0.55,0.28,0.5,0.5,0.28,0.5,0.28,0.5,0.5,0.44,0.28,0.25,0.55,0.44,0.44,0.28,0.28,0.25,0.55,0.5,0.44,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.28,0.78,0.78,0.5,0.5,0.5,0.39,0.5,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">account for individual cell depletion and immunosuppressive </text>
   <text y="154.089" x="49.606,53.602,56.437,59.434,63.43,67.426,69.928,73.429" svgx:width="0.44,0.33,0.33,0.44,0.44,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">effects.</text>
   <text y="181.089" x="49.606,55.105,59.605,64.105" svgx:width="0.61,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">P977</text>
   <text y="192.087" x="49.606,53.107,58.111,62.611,66.607,70.108,73.105,75.607,80.107,84.607,87.604,90.106,94.606,99.61,101.86,106.36,109.357,111.607,114.604,119.608,123.604,125.854,129.85,132.847,135.844,139.84,143.836,146.833,150.334,152.584,157.084,160.081,162.331,164.833,167.83,171.826,176.326,180.322,184.822,189.826,194.326,198.322,202.822,205.324,209.32,211.57,213.82,218.32,220.57,225.574,229.57,234.07,239.074,243.07" svgx:width="0.39,0.56,0.5,0.44,0.39,0.33,0.28,0.5,0.5,0.33,0.28,0.5,0.56,0.25,0.5,0.33,0.25,0.33,0.56,0.44,0.25,0.44,0.33,0.33,0.44,0.44,0.33,0.39,0.25,0.5,0.33,0.25,0.28,0.33,0.44,0.5,0.44,0.5,0.56,0.5,0.44,0.5,0.28,0.44,0.25,0.25,0.5,0.25,0.56,0.44,0.5,0.56,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Investigation of the effects of itraconazole, a probe </text>
   <text y="203.085" x="49.606,56.104,62.602,68.101,72.601,79.099,81.349,85.849,90.853,95.857,98.107,103.606,106.603,111.103,113.605,118.105,122.101,126.601,131.605,135.601,140.101,143.098,147.094,149.596,154.6,156.85,159.352,164.356,169.36,171.862,176.866,179.368,182.365,186.865,190.861,193.111,195.361,199.861,204.865,207.115,210.112,215.116,219.112" svgx:width="0.72,0.72,0.61,0.5,0.72,0.25,0.5,0.56,0.56,0.25,0.61,0.33,0.5,0.28,0.5,0.44,0.5,0.56,0.44,0.5,0.33,0.44,0.28,0.56,0.25,0.28,0.56,0.56,0.28,0.56,0.28,0.33,0.5,0.44,0.25,0.25,0.5,0.56,0.25,0.33,0.56,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">CYP3A and P-glycoprotein inhibitor, on the </text>
   <text y="214.083" x="49.606,54.61,59.614,64.114,68.11,75.607,80.107,84.103,88.603,93.607,96.109,101.113,105.109,108.106,110.608,114.604,118.105,120.355,124.855,127.852,130.102,134.098,138.094,142.09,146.59,149.092,151.594,154.591,157.093,164.59,169.09,174.094,176.344,179.341,186.343,192.841,199.843,202.84,207.34,211.84,216.34,220.84" svgx:width="0.56,0.56,0.5,0.44,0.83,0.5,0.44,0.5,0.56,0.28,0.56,0.44,0.33,0.28,0.44,0.39,0.25,0.5,0.33,0.25,0.44,0.44,0.44,0.5,0.28,0.28,0.33,0.28,0.83,0.5,0.56,0.25,0.33,0.78,0.72,0.78,0.33,0.5,0.5,0.5,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">pharmacokinetics of ceralifimod (ONO-4641)</text>
   <text y="225.081" x="49.606,54.61,56.86,63.358,66.355,70.855,74.356,77.857,81.853" svgx:width="0.56,0.25,0.72,0.33,0.5,0.39,0.39,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">S Krösser</text>
   <text y="222.583" x="84.85" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="225.103" x="87.775,90.025,92.275,97.279,99.529,108.025,112.525,115.027,119.527" svgx:width="0.25,0.25,0.56,0.25,0.94,0.5,0.28,0.5,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, P Wolna</text>
   <text y="222.583" x="123.522" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="225.103" x="126.448,128.698,130.948,139.444,141.694,148.192,152.188,156.688" svgx:width="0.25,0.25,0.94,0.25,0.72,0.44,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, W Geng</text>
   <text y="222.583" x="161.187" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">2</text>
   <text y="225.103" x="164.112,166.362,168.612,175.11,177.36,185.361,189.357,191.859,195.36,199.86,204.36,208.356,212.856" svgx:width="0.25,0.25,0.72,0.25,0.89,0.44,0.28,0.39,0.5,0.5,0.44,0.5,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, N Matsunaga</text>
   <text y="222.583" x="216.851" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">3</text>
   <text y="225.103" x="219.776,222.026,224.276,230.279,232.529,239.027,243.023,246.524,250.52,255.02,259.016,265.514" svgx:width="0.25,0.25,0.67,0.25,0.72,0.44,0.39,0.44,0.5,0.44,0.72,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, C Hasegawa</text>
   <text y="222.583" x="269.509" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">3</text>
   <text y="233.581" x="49.608" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">1</text>
   <text y="236.103" x="52.531,60.028,64.024,67.525,71.521,75.517,77.767,83.77,90.268,94.768,100.267,102.517,104.767,111.265,115.765,119.266,125.764,129.265,131.767,136.267,140.767,143.269,145.519,147.769,154.267,158.263,161.764,168.262,172.762,177.262,181.258,183.508" svgx:width="0.83,0.44,0.39,0.44,0.44,0.25,0.67,0.72,0.5,0.61,0.25,0.25,0.72,0.5,0.39,0.72,0.39,0.28,0.5,0.5,0.28,0.25,0.25,0.72,0.44,0.39,0.72,0.5,0.5,0.44,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Merck KGaA, Darmstadt, Germany, </text>
   <text y="233.583" x="185.756" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">2</text>
   <text y="236.103" x="188.681,194.18,201.677,208.175,210.425,214.925,218.921,222.422,226.922,231.422,235.922,238.172,240.422,243.419,247.919,251.915,254.165,256.415" svgx:width="0.61,0.83,0.72,0.25,0.5,0.44,0.39,0.5,0.5,0.5,0.25,0.25,0.33,0.5,0.44,0.25,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">EMD Serono, Inc., </text>
   <text y="247.101" x="49.604,55.103,57.605,60.107,62.609,66.605,70.106,72.608,76.604,81.104,83.354,85.604,93.101,98.6,100.85,103.1,109.598,114.098,116.6,119.102,123.098,127.598,129.848,134.348,136.85,141.35,143.852,147.848,151.349,153.599" svgx:width="0.61,0.28,0.28,0.28,0.44,0.39,0.28,0.44,0.5,0.25,0.25,0.83,0.61,0.25,0.25,0.72,0.5,0.28,0.28,0.44,0.5,0.25,0.5,0.28,0.5,0.28,0.44,0.39,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Billerica, MA, United States, </text>
   <text y="244.583" x="155.85" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">3</text>
   <text y="247.103" x="158.775,165.273,169.773,174.273,176.523,182.022,186.522,191.022,194.523,201.021,205.521,209.517,213.513,218.013,220.515,223.017,227.013,231.513,234.015,236.265,242.268,246.768,249.018,251.268,253.518,258.522,261.024,265.524,267.774,270.024" svgx:width="0.72,0.5,0.5,0.25,0.61,0.5,0.5,0.39,0.72,0.5,0.44,0.44,0.5,0.28,0.28,0.44,0.5,0.28,0.25,0.67,0.5,0.25,0.25,0.25,0.56,0.28,0.5,0.25,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Ono Pharmaceutical Co., Ltd., </text>
   <text y="258.101" x="49.605,52.602,57.102,61.602,65.103,69.603,73.599,76.101,78.351,80.601,84.597,89.097,93.597,98.097" svgx:width="0.33,0.5,0.5,0.39,0.5,0.44,0.28,0.25,0.25,0.44,0.5,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Ibaraki, Japan</text>
   <text y="285.101" x="49.605,55.608,60.108,64.104,69.108,73.608,77.442,81.942,86.946,91.95,96.954,99.951" svgx:width="0.67,0.5,0.44,0.56,0.5,0.44,0.5,0.56,0.56,0.56,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Background: </text>
   <text y="285.101" x="102.003,108.006,112.002,114.999,118.995,121.497,123.999,126.996,129.498,136.5,141.0,145.5,147.552,150.549,157.047,163.545,170.043,173.04,177.54,182.04,186.54,191.04,194.037,196.089,198.591,202.092,204.144,208.14,212.64,214.692,219.192,222.189,226.185,228.687,230.937,232.989,236.49,240.486,242.988,246.984,250.98,253.482,255.984,260.484,264.48,266.73,268.782,273.282,277.782,282.282" svgx:width="0.67,0.44,0.33,0.44,0.28,0.28,0.33,0.28,0.78,0.5,0.5,0.25,0.33,0.72,0.72,0.72,0.33,0.5,0.5,0.5,0.5,0.33,0.25,0.28,0.39,0.25,0.44,0.5,0.25,0.5,0.33,0.44,0.28,0.25,0.25,0.39,0.44,0.28,0.44,0.44,0.28,0.28,0.5,0.44,0.25,0.25,0.5,0.5,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Ceralifimod (ONO-4641) is an oral, selective, non-</text>
   <text y="296.099" x="49.605,54.105,57.102,61.602,66.102,69.099,73.599,78.099,80.349,82.599,84.453,87.954,92.454,96.954,99.456,103.956,108.456,112.956,116.457,118.959,123.459,127.455,130.452,134.952,137.949,142.449,146.949,151.449,154.95,159.45,163.95,167.946,170.448,174.444,176.694,178.548,181.545,185.541,189.537,193.533,198.033,200.535,205.035,207.852,210.849,215.349,217.599,219.453,223.449,227.949,232.449,234.699,236.553,239.55,244.05,246.3,248.154,252.15,256.65,261.15,265.65,268.152,271.653,274.155,276.405,278.259,280.761,285.261" svgx:width="0.5,0.33,0.5,0.5,0.33,0.5,0.5,0.25,0.25,0.55,0.39,0.5,0.5,0.28,0.5,0.5,0.5,0.39,0.28,0.5,0.44,0.33,0.5,0.33,0.5,0.5,0.5,0.39,0.5,0.5,0.44,0.28,0.44,0.25,0.55,0.33,0.44,0.44,0.44,0.5,0.28,0.5,0.33,0.33,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.33,0.5,0.25,0.55,0.44,0.5,0.5,0.5,0.28,0.39,0.28,0.25,0.55,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">prodrug, sphingosine-1-phosphate receptor-1 and -5 agonist in </text>
   <text y="307.097" x="49.605,53.601,56.103,58.605,63.105,65.607,69.603,73.599,76.101,78.054,82.554,86.55,91.05,95.046,97.548,102.048,106.548,113.55,117.546,122.046,124.548,126.501,129.498,133.998,136.995,138.948,141.45,145.95,149.946,151.899,154.401,157.398,161.394,165.39,167.892,174.894,178.89,183.39,185.892,187.845,192.345,195.342,197.295,200.292,204.288,206.79,210.786,215.286,218.787,221.289,225.789,230.289,233.286,236.283,240.279,247.281,249.783,252.285,254.787,257.289,261.789,266.289,268.242,275.244,279.744,282.246" svgx:width="0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.5,0.44,0.5,0.44,0.28,0.5,0.5,0.78,0.44,0.5,0.28,0.25,0.33,0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.5,0.33,0.25,0.33,0.44,0.28,0.44,0.5,0.39,0.28,0.5,0.5,0.33,0.33,0.44,0.78,0.28,0.28,0.28,0.28,0.5,0.5,0.25,0.78,0.5,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">clinical development for the treatment of relapsing-remitting mul-</text>
   <text y="318.095" x="49.605,52.107,54.609,59.109,61.611,65.607,67.857,69.576,73.077,77.073,79.575,83.571,86.568,91.068,94.569,97.071,100.572,102.822" svgx:width="0.28,0.28,0.5,0.28,0.44,0.25,0.55,0.39,0.44,0.28,0.44,0.33,0.5,0.39,0.28,0.39,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">tiple sclerosis. </text>
   <text y="318.095" x="106.791,109.788,114.288,116.538,118.257,122.253,124.755,127.257,130.425" svgx:width="0.33,0.5,0.25,0.55,0.44,0.28,0.28,0.39,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">In vitro</text>
   <text y="318.095" x="134.925,137.175,138.894,142.395,144.897,149.397,153.897,156.399,160.395,163.896,166.146,167.865,172.365,176.361,180.861,184.857,187.107,188.826,192.327,196.827,201.327,207.825,212.325,214.575,216.294,218.796,223.296,227.292,229.794,232.044,233.763,237.759,241.755,244.752,248.748,251.25,253.752,256.749,259.251,266.253,270.753,275.253,277.503,279.222,281.724,285.225" svgx:width="0.25,0.55,0.39,0.28,0.5,0.5,0.28,0.44,0.39,0.25,0.55,0.5,0.44,0.5,0.44,0.25,0.55,0.39,0.5,0.5,0.72,0.5,0.25,0.55,0.28,0.5,0.44,0.28,0.25,0.55,0.44,0.44,0.33,0.44,0.28,0.28,0.33,0.28,0.78,0.5,0.5,0.25,0.55,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;"> studies have shown that ceralifimod is </text>
   <text y="329.093" x="49.605,53.106,55.608,60.108,66.606,69.108,73.608,75.858,77.523,81.519,86.019,90.519,92.769,94.434,98.934,102.93,105.927,108.429,110.931,114.927,117.429,119.931,124.431,126.681,128.346,135.348,139.344,141.846,145.842,150.342,154.842,157.344,159.846,163.842,167.838,172.338,174.588,176.838,178.503,185.505,189.501,192.003,196.503,199.005,203.505,205.755,207.42,211.92,216.42,218.67,220.335,224.331,228.831,231.333,235.833,239.829,244.329,247.326,251.826,258.828,262.824,265.074,266.739,271.743,276.243,280.743,285.243" svgx:width="0.39,0.28,0.5,0.72,0.28,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.5,0.44,0.33,0.28,0.28,0.44,0.28,0.28,0.5,0.25,0.55,0.78,0.44,0.28,0.44,0.5,0.5,0.28,0.28,0.44,0.44,0.5,0.25,0.25,0.55,0.78,0.44,0.28,0.5,0.28,0.5,0.25,0.55,0.5,0.5,0.25,0.55,0.44,0.5,0.28,0.5,0.44,0.5,0.33,0.5,0.78,0.44,0.25,0.55,0.56,0.5,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">slowly and partially metabolized, mainly by cytochrome P450 </text>
   <text y="340.091" x="49.605,52.602,58.605,65.103,70.107,73.104,75.354,76.434,80.934,87.432,91.932,94.182,95.262,99.258,103.758,108.258,110.508,111.588,117.591,124.089,129.093,133.593,140.091,144.591,146.841,149.091,150.171,154.167,158.667,163.167,165.417,166.497,168.999,173.499,177.495,179.997,182.247,183.327,185.829,188.331,190.581,191.661,194.163,197.664,199.914,200.994,204.99,207.24,208.32,211.821,216.321,220.821,224.322,226.824,229.821,233.817,236.319,240.315,242.565,243.645,248.145,251.142,253.392,254.472,256.974,261.474,265.47,267.72,268.8,273.3,276.297,280.797,285.297" svgx:width="0.33,0.67,0.72,0.56,0.33,0.25,0.55,0.5,0.72,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.67,0.72,0.56,0.5,0.72,0.5,0.25,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.28,0.5,0.44,0.28,0.25,0.55,0.28,0.28,0.25,0.55,0.28,0.39,0.25,0.55,0.44,0.25,0.55,0.39,0.5,0.5,0.39,0.28,0.33,0.44,0.28,0.44,0.25,0.55,0.5,0.33,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.5,0.33,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(CYP) 3A4 and CYP3A5, and that it is a substrate of the drug </text>
   <text y="351.089" x="49.605,52.107,55.104,59.1,63.6,67.101,71.601,76.101,79.098,81.6,85.596,88.593,90.843,95.847,98.844,103.344,105.846,110.346,114.342,118.842,123.342,126.339,130.839,133.341,137.337,139.839,144.339,146.589,149.586,154.59,159.09,163.59,166.587" svgx:width="0.28,0.33,0.44,0.5,0.39,0.5,0.5,0.33,0.28,0.44,0.33,0.25,0.56,0.33,0.5,0.28,0.5,0.44,0.5,0.5,0.33,0.5,0.28,0.44,0.28,0.5,0.25,0.33,0.56,0.5,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">transporter P-glycoprotein (Pgp).</text>
   <text y="362.087" x="49.605,56.607,61.611,64.608,68.604,72.6,75.597,78.099,82.599,86.595,90.096,93.093" svgx:width="0.78,0.56,0.33,0.44,0.44,0.33,0.28,0.5,0.44,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Objectives: </text>
   <text y="362.087" x="96.333,101.832,106.332,110.328,112.578,113.568,118.068,122.568,125.565,130.065,134.565,138.066,142.062,144.312,145.302,149.802,152.799,155.049,156.039,158.541,163.041,165.543,169.044,171.294,172.284,179.286,183.282,187.278,191.778,195.774,200.274,202.776,206.277,208.779,211.281,215.277,217.527,218.517,223.017,226.014,230.514,235.014,238.011,242.511,245.508,250.008,254.508,256.75800000000004,257.748,260.25,264.75,267.252,271.248,274.245,278.241,282.237" svgx:width="0.61,0.5,0.44,0.25,0.55,0.5,0.5,0.33,0.5,0.5,0.39,0.44,0.25,0.55,0.5,0.33,0.25,0.55,0.28,0.5,0.28,0.39,0.25,0.55,0.78,0.44,0.44,0.5,0.44,0.5,0.28,0.39,0.28,0.28,0.44,0.25,0.55,0.5,0.33,0.5,0.5,0.33,0.5,0.33,0.5,0.5,0.25,0.55,0.28,0.5,0.28,0.44,0.33,0.44,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">The purpose of this mechanistic drug-drug interac-</text>
   <text y="373.085" x="49.605,52.107,54.609,59.109,63.609,65.85900000000001,66.948,69.945,76.443,82.941,85.938,88.935,91.185,92.274,95.775,98.277,102.777,107.277,111.777,114.027,115.116,121.614,125.61,129.111,131.361,132.45,134.952,139.452,141.702,142.791,145.293,149.793,154.293,158.289,161.79,164.292,166.794,171.294,175.29,177.792,181.788,184.038,185.127,187.629,192.129,196.125,198.375,199.464,203.46,206.295,209.292,213.288,217.284,219.786,223.287,225.537,226.626,231.126,234.123,236.373,237.462,240.459,244.455,248.955,252.951,256.947,259.449,263.445,267.945,270.195,271.284,275.784,278.781,282.777,285.279" svgx:width="0.28,0.28,0.5,0.5,0.25,0.55,0.33,0.72,0.72,0.33,0.33,0.25,0.55,0.39,0.28,0.5,0.5,0.5,0.25,0.55,0.72,0.44,0.39,0.25,0.55,0.28,0.5,0.25,0.55,0.28,0.5,0.5,0.44,0.39,0.28,0.28,0.5,0.44,0.28,0.44,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.44,0.33,0.33,0.44,0.44,0.28,0.39,0.25,0.55,0.5,0.33,0.25,0.55,0.33,0.44,0.5,0.44,0.44,0.28,0.44,0.5,0.25,0.55,0.5,0.33,0.44,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">tion (DDI) study was to investigate the effects of repeated oral </text>
   <text y="384.083" x="49.605,54.105,58.605,62.106,66.102,69.603,71.763,76.263,79.26,81.42,83.922,86.424,89.421,93.417,97.413,101.913,106.413,110.409,114.405,118.905,121.407,125.403,127.653,129.813,133.809,135.969,140.469,143.466,147.966,150.468,154.968,157.47,161.97,166.47,168.972,172.968,175.128,178.629,181.131,184.128,188.628,193.128,197.628,199.788,205.791,212.289,217.293,221.793,227.796,229.956,233.952,238.452,242.952,245.112,250.116,254.616,259.116,261.276,263.778,268.278,272.778,275.28,279.78,282.282" svgx:width="0.5,0.5,0.39,0.44,0.39,0.25,0.5,0.33,0.25,0.28,0.28,0.33,0.44,0.44,0.5,0.5,0.44,0.44,0.5,0.28,0.44,0.25,0.25,0.44,0.25,0.5,0.33,0.5,0.28,0.5,0.28,0.5,0.5,0.28,0.44,0.25,0.39,0.28,0.33,0.5,0.5,0.5,0.25,0.67,0.72,0.56,0.5,0.72,0.25,0.44,0.5,0.5,0.25,0.56,0.5,0.5,0.25,0.28,0.5,0.5,0.28,0.5,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">doses of itraconazole, a prototypic strong CYP3A and Pgp inhibi-</text>
   <text y="395.081" x="49.605,52.107,56.607,59.244,61.494,63.879,68.379,72.879,75.264,77.766,82.266,86.262,88.647,93.147,97.647,101.643,104.64,111.642,115.638,119.634,124.134,128.634,131.136,135.636,139.632,142.134,144.636,148.632,152.133,154.518,157.515,162.519,169.017,172.014,174.399,178.899,181.896,184.281,188.277,192.273,195.27,199.266,201.768,204.27,207.267,209.769,216.771,221.271,225.771,228.021,230.406,233.907,238.407,242.403,246.399,248.901,251.898,254.4,258.396,262.392,264.894,267.396,271.896,274.281,276.783,281.283,285.279" svgx:width="0.28,0.5,0.33,0.25,0.25,0.5,0.5,0.25,0.28,0.5,0.44,0.25,0.5,0.5,0.44,0.33,0.78,0.44,0.44,0.5,0.5,0.28,0.5,0.44,0.28,0.28,0.44,0.39,0.25,0.33,0.56,0.72,0.33,0.25,0.5,0.33,0.25,0.44,0.44,0.33,0.44,0.28,0.28,0.33,0.28,0.78,0.5,0.5,0.25,0.25,0.39,0.5,0.44,0.44,0.28,0.33,0.28,0.44,0.44,0.28,0.28,0.5,0.25,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">tor, on the pharmacokinetics (PK) of ceralifimod, specifically the </text>
   <text y="406.079" x="49.605,52.602,57.102,59.604,63.6,66.255,70.755,73.752,76.407,82.41,88.908,93.912,98.412,104.415,107.07,109.572,114.072,116.727,120.723,124.719,127.716,131.712,134.214,136.716,139.713,142.215,149.217,153.717,158.217,160.863,167.865,171.861,174.363,178.359,182.859,187.359,189.861,192.363,195.864,202.866,205.521,209.517,214.017,218.517,221.172,223.674,228.174,232.17,234.825,237.822,242.322,244.824,248.82,251.475,255.975,258.972,261.627,266.631,271.131,275.631,278.286,280.788,285.288" svgx:width="0.33,0.5,0.28,0.44,0.25,0.5,0.33,0.25,0.67,0.72,0.56,0.5,0.72,0.25,0.28,0.5,0.25,0.44,0.44,0.33,0.44,0.28,0.28,0.33,0.28,0.78,0.5,0.5,0.25,0.78,0.44,0.28,0.44,0.5,0.5,0.28,0.28,0.39,0.78,0.25,0.44,0.5,0.5,0.25,0.28,0.5,0.44,0.25,0.33,0.5,0.28,0.44,0.25,0.5,0.33,0.25,0.56,0.5,0.5,0.25,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">role of CYP3A in ceralifimod metabolism and the role of Pgp in </text>
   <text y="417.077" x="49.605,52.107,56.607,60.603,62.853,66.354,70.854,74.355,76.857,80.853,87.855,90.357,94.353,96.603,100.599,105.099,109.599,114.099,117.6,122.1,125.097,129.093,131.343,135.843,138.84,141.09,145.086,149.082,152.079,156.075,158.577,161.079,164.076,166.578,173.58,178.08,182.58" svgx:width="0.28,0.5,0.44,0.25,0.39,0.5,0.39,0.28,0.44,0.78,0.28,0.44,0.25,0.44,0.5,0.5,0.5,0.39,0.5,0.33,0.44,0.25,0.5,0.33,0.25,0.44,0.44,0.33,0.44,0.28,0.28,0.33,0.28,0.78,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">the systemic exposure of ceralifimod.</text>
   <text y="428.075" x="49.605,58.101,62.097,65.094,70.098,74.598,79.602,83.103,86.1" svgx:width="0.94,0.44,0.33,0.56,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Methods: </text>
   <text y="428.075" x="91.716,96.216,100.716,102.966,106.332,110.832,114.828,118.824,121.326,123.828,128.328,132.828,135.078,138.444,142.944,147.444,149.946,154.446,158.946,161.448,165.444,169.44,172.437,175.938,178.188,181.554,184.551,189.051,191.301,194.667,201.669,205.665,210.165,212.415,214.665,218.031,222.531,227.031,229.281,232.647,239.145,243.645,250.647,254.643,259.143,262.14,264.39,267.756,274.254,278.25,281.247,285.243" svgx:width="0.5,0.5,0.25,0.55,0.5,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.5,0.28,0.5,0.5,0.28,0.44,0.44,0.33,0.39,0.25,0.55,0.33,0.5,0.25,0.55,0.78,0.44,0.5,0.25,0.25,0.55,0.5,0.5,0.25,0.55,0.72,0.5,0.78,0.44,0.5,0.33,0.25,0.55,0.72,0.44,0.33,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">16 healthy volunteers (6 men, 10 women) were </text>
   <text y="439.073" x="49.605,52.107,56.607,60.603,63.105,67.605,72.105,76.101,80.601,82.428,84.93,89.43,91.257,93.759,98.259,100.761,104.262,106.089,110.589,115.089,119.085,123.585,126.582,129.084,133.08,137.58,141.576,144.078,146.328,148.155,151.656,155.652,160.152,164.652,168.648,173.148,175.65,178.152,182.148,184.65,186.9,188.727,191.229,197.727,202.227,205.224,209.724,213.72,216.717,219.219,223.719,228.219,230.046,232.548,235.545,238.047,242.043,244.545,246.795,248.622,251.619,256.119,257.946,260.448,264.948,268.944,270.771,273.768,276.27,279.267,282.768,285.27" svgx:width="0.28,0.5,0.44,0.28,0.5,0.5,0.44,0.5,0.25,0.28,0.5,0.25,0.28,0.5,0.28,0.39,0.25,0.5,0.5,0.44,0.5,0.33,0.28,0.44,0.5,0.44,0.28,0.25,0.25,0.39,0.44,0.5,0.5,0.44,0.5,0.28,0.28,0.44,0.28,0.25,0.25,0.28,0.72,0.5,0.33,0.5,0.44,0.33,0.28,0.5,0.5,0.25,0.28,0.33,0.28,0.44,0.28,0.25,0.25,0.33,0.5,0.25,0.28,0.5,0.44,0.25,0.33,0.28,0.33,0.39,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">included in this open-label, sequential, two-period trial. In the first </text>
   <text y="450.071" x="49.605,54.105,58.101,61.098,63.6,68.1,72.6,74.85,77.028,81.024,85.02,88.017,92.013,94.515,97.017,100.014,102.516,109.518,114.018,118.518,120.696,125.7,132.198,134.376,140.874,144.87,148.371,150.549,154.545,158.046,161.547,165.543,169.044,172.545,176.541,181.041,183.219,187.719,192.219,196.719,200.715,203.712,205.89,208.887,212.883,216.384,218.886,221.388,225.888,230.388,232.566,236.562,241.062,245.562,250.062,252.564,255.066,257.568,262.068,266.568,270.069,272.247,276.243,280.743,285.243" svgx:width="0.5,0.44,0.33,0.28,0.5,0.5,0.25,0.25,0.44,0.44,0.33,0.44,0.28,0.28,0.33,0.28,0.78,0.5,0.5,0.25,0.56,0.72,0.25,0.72,0.44,0.39,0.25,0.44,0.39,0.39,0.44,0.39,0.39,0.44,0.5,0.25,0.5,0.5,0.5,0.44,0.33,0.25,0.33,0.44,0.39,0.28,0.28,0.5,0.5,0.25,0.44,0.5,0.5,0.5,0.28,0.28,0.28,0.5,0.5,0.39,0.25,0.44,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">period, ceralifimod PK was assessed under fasting conditions and </text>
   <text y="461.069" x="49.605,56.103,58.605,61.107,65.607,70.107,74.607,77.109,79.809,82.311,84.813,87.81,91.806,95.802,100.302,104.802,108.798,112.794,117.294,119.796,123.792,126.492,130.488,134.988,138.984,143.484,150.486,152.988,157.488,159.99,163.491,165.993,168.99,172.986,175.488,177.99,182.49,186.99,189.492,192.192,195.693,200.193,204.693,207.195,211.191,215.187,217.689,221.19,223.89,226.887,230.883,234.879,238.875,241.377,245.877,249.873,254.373,257.073,261.069,263.769,267.27,269.772,274.272,278.772,281.274,285.27" svgx:width="0.72,0.28,0.28,0.5,0.5,0.5,0.28,0.25,0.28,0.28,0.33,0.44,0.44,0.5,0.5,0.44,0.44,0.5,0.28,0.44,0.25,0.44,0.5,0.44,0.5,0.78,0.28,0.5,0.28,0.39,0.28,0.33,0.44,0.28,0.28,0.5,0.5,0.28,0.25,0.39,0.5,0.5,0.28,0.44,0.44,0.28,0.39,0.25,0.33,0.44,0.44,0.44,0.28,0.5,0.44,0.5,0.25,0.44,0.25,0.39,0.28,0.5,0.5,0.28,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">without itraconazole coadministration: subjects received a single </text>
   <text y="472.067" x="49.605,54.105,56.355,60.855,65.355,68.352,75.354,79.854,82.275,86.775,91.275,94.776,98.772,101.193,105.693,108.69,111.111,115.107,119.103,122.1,126.096,128.598,131.1,134.097,136.599,143.601,148.101,152.601,155.022,159.522,164.022,166.443,172.941,176.937,181.437,183.858,188.358,190.608,193.029,196.026,200.526,202.947,205.449,209.949,213.945,216.366,219.867,223.863,227.859,232.359,236.859,241.359,243.78,248.28,252.276,255.273,257.775,262.275,266.775,269.025,271.446,275.442,279.438,282.264" svgx:width="0.5,0.25,0.5,0.5,0.33,0.78,0.5,0.25,0.5,0.5,0.39,0.44,0.25,0.5,0.33,0.25,0.44,0.44,0.33,0.44,0.28,0.28,0.33,0.28,0.78,0.5,0.5,0.25,0.5,0.5,0.25,0.72,0.44,0.5,0.25,0.5,0.25,0.25,0.33,0.5,0.25,0.28,0.5,0.44,0.25,0.39,0.44,0.44,0.5,0.5,0.5,0.25,0.5,0.44,0.33,0.28,0.5,0.5,0.25,0.25,0.44,0.44,0.33,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">0.15-mg dose of ceralifimod on Day 1. In the second period, cer-</text>
   <text y="483.065" x="49.605,53.601,56.103,58.605,61.602,64.104,71.106,75.606,80.106,82.5,87.504,94.002,96.396,102.894,106.89,110.391,112.785,116.781,120.282,123.783,127.779,131.28,134.781,138.777,143.277,145.671,148.173,152.673,155.067,159.063,163.563,170.565,175.065,177.567,182.067,186.063,188.565,191.067,195.567,200.067,202.461,208.959,211.461,213.963,218.463,220.857,223.359,225.861,228.858,232.854,236.85,241.35,245.85,249.846,253.842,258.342,260.844,264.84,267.342,269.736,273.237,277.737,282.237" svgx:width="0.44,0.28,0.28,0.33,0.28,0.78,0.5,0.5,0.25,0.56,0.72,0.25,0.72,0.44,0.39,0.25,0.44,0.39,0.39,0.44,0.39,0.39,0.44,0.5,0.25,0.28,0.5,0.25,0.44,0.5,0.78,0.5,0.28,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.72,0.28,0.28,0.5,0.25,0.28,0.28,0.33,0.44,0.44,0.5,0.5,0.44,0.44,0.5,0.28,0.44,0.28,0.25,0.39,0.5,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">alifimod PK was assessed in combination with itraconazole: sub-</text>
   <text y="494.063" x="49.605,52.107,56.103,60.099,62.601,66.102,68.271,71.268,75.264,79.26,83.256,85.758,90.258,94.254,98.754,100.923,105.423,109.923,114.423,116.592,123.594,128.094,130.263,132.765,135.267,138.264,142.26,146.256,150.756,155.256,159.252,163.248,167.748,170.25,174.246,176.415,180.915,185.415,189.411,193.407,195.576,200.076,204.072,206.574,209.076,213.576,215.745,218.742,223.242,226.239,228.408,232.908,237.408,239.577,244.077,248.073,252.573,256.074,258.243,261.744,264.246,268.242,271.239,273.741,276.243,280.743,285.243" svgx:width="0.28,0.44,0.44,0.28,0.39,0.25,0.33,0.44,0.44,0.44,0.28,0.5,0.44,0.5,0.25,0.5,0.5,0.5,0.25,0.78,0.5,0.25,0.28,0.28,0.33,0.44,0.44,0.5,0.5,0.44,0.44,0.5,0.28,0.44,0.25,0.5,0.5,0.44,0.44,0.25,0.5,0.44,0.28,0.28,0.5,0.25,0.33,0.5,0.33,0.25,0.5,0.5,0.25,0.5,0.44,0.5,0.39,0.25,0.39,0.28,0.44,0.33,0.28,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">jects received 200 mg itraconazole once daily for 14 days starting </text>
   <text y="505.061" x="49.605,54.105,58.605,60.855,61.728,68.226,72.222,76.722,78.972,79.845,84.345,88.845,91.095,91.968,95.964,100.464,104.964,107.214,108.087,112.083,114.333,115.206,118.707,122.703,126.699,131.199,135.699,140.199,142.449,143.322,146.823,149.325,153.825,158.325,160.827,164.823,167.073,167.946,172.446,176.946,180.447,184.443,186.693,187.566,192.066,195.063,197.313,198.186,202.182,206.178,209.175,213.171,215.673,218.175,221.172,223.674,230.676,235.176,239.676,241.926,242.799,247.299,249.549,254.049,258.549,260.799,261.672,268.674,273.174,275.424,276.297,280.797,285.297" svgx:width="0.5,0.5,0.25,0.55,0.72,0.44,0.5,0.25,0.55,0.5,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.44,0.25,0.55,0.39,0.44,0.44,0.5,0.5,0.5,0.25,0.55,0.39,0.28,0.5,0.5,0.28,0.44,0.25,0.55,0.5,0.5,0.39,0.44,0.25,0.55,0.5,0.33,0.25,0.55,0.44,0.44,0.33,0.44,0.28,0.28,0.33,0.28,0.78,0.5,0.5,0.25,0.55,0.5,0.25,0.5,0.5,0.25,0.55,0.78,0.5,0.25,0.55,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">on Day 23 and a second single dose of ceralifimod 0.15 mg on </text>
   <text y="516.059" x="49.605,56.103,60.099,64.599,66.849,67.533,72.033,76.533,78.783,79.467,82.464,85.461,89.961,94.461,97.458,99.96,104.46,106.71,107.394,111.894,115.89,120.39,122.64,123.324,127.824,130.821,133.071,133.755,136.257,138.759,141.756,145.752,149.748,154.248,158.748,162.744,166.74,171.24,173.742,177.738,179.988,180.672,184.668,189.168,196.17,198.672,203.172,205.674,209.175,211.677,214.674,218.67,221.172,223.674,228.174,232.674,235.671,237.921,240.171,240.846,245.85,249.846,252.843,255.345,259.341,261.843,264.093,264.777,269.277,271.779,276.279,280.779,285.279" svgx:width="0.72,0.44,0.5,0.25,0.55,0.5,0.5,0.25,0.55,0.33,0.33,0.5,0.5,0.33,0.28,0.5,0.25,0.55,0.5,0.44,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.28,0.28,0.33,0.44,0.44,0.5,0.5,0.44,0.44,0.5,0.28,0.44,0.25,0.55,0.44,0.5,0.78,0.28,0.5,0.28,0.39,0.28,0.33,0.44,0.28,0.28,0.5,0.5,0.33,0.25,0.25,0.55,0.56,0.44,0.33,0.28,0.44,0.28,0.25,0.55,0.5,0.28,0.5,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Day 26 (fourth day of itraconazole administration). Serial blood </text>
   <text y="527.057" x="49.605,53.106,57.102,64.104,68.604,71.106,75.102,78.603,80.952,84.948,89.448,91.95,94.452,98.448,102.444,104.946,108.942,113.442,115.791,120.291,124.791,128.787,131.784,134.133,138.633,143.133,147.633,149.982,154.482,158.982,163.482,166.479,169.98,172.329,176.829,181.329,184.83,187.332,189.681,193.677,197.673,200.67,204.666,207.168,209.67,212.667,215.169,222.171,226.671,231.171,233.52,238.02,242.52,246.021,248.523,253.023,257.523,259.872,262.374,266.874,269.223,273.723,278.223,280.725,285.225" svgx:width="0.39,0.44,0.78,0.5,0.28,0.44,0.39,0.25,0.44,0.5,0.28,0.28,0.44,0.44,0.28,0.44,0.5,0.25,0.5,0.5,0.44,0.33,0.25,0.5,0.5,0.5,0.25,0.5,0.5,0.5,0.33,0.39,0.25,0.5,0.5,0.39,0.28,0.25,0.44,0.44,0.33,0.44,0.28,0.28,0.33,0.28,0.78,0.5,0.5,0.25,0.5,0.5,0.39,0.28,0.5,0.5,0.25,0.28,0.5,0.25,0.5,0.5,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">samples collected over 312 hours post ceralifimod dosing in both </text>
   <text y="538.055" x="49.605,53.106,55.608,60.108,64.608,69.108,71.358,72.069,76.569,80.565,83.562,86.064,90.564,95.064,98.565,100.815,101.526,108.024,112.02,115.017,119.013,121.263,121.974,125.97,129.471,132.972,136.968,140.469,143.97,147.966,152.466,154.716,155.427,159.927,162.429,166.425,168.675,169.386,173.886,177.882,180.384,182.886,187.386,191.382,193.884,197.88,202.38,204.63,205.341,209.841,212.343,216.843,221.343,224.34,228.84,232.836,235.833,238.83,243.33,246.327,253.329,257.325,261.825,265.821,269.817,272.067,272.778,275.28,277.782,282.282" svgx:width="0.39,0.28,0.5,0.5,0.5,0.25,0.55,0.5,0.44,0.33,0.28,0.5,0.5,0.39,0.25,0.55,0.72,0.44,0.33,0.44,0.25,0.55,0.44,0.39,0.39,0.44,0.39,0.39,0.44,0.5,0.25,0.55,0.5,0.28,0.44,0.25,0.55,0.5,0.44,0.28,0.28,0.5,0.44,0.28,0.44,0.5,0.25,0.55,0.5,0.28,0.5,0.5,0.33,0.5,0.44,0.33,0.33,0.5,0.33,0.78,0.44,0.5,0.44,0.44,0.25,0.55,0.28,0.28,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">study periods were assessed via validated high-performance liq-</text>
   <text y="549.053" x="49.605,54.105,56.607,61.107,63.348,67.344,71.844,74.841,79.341,86.343,90.339,92.841,97.341,101.841,104.838,108.834,113.334,117.834,122.334,124.575,131.073,133.575,136.077,140.577,142.818,145.32,149.316,153.816,158.316,162.312,169.314,171.555,178.557,182.553,186.054,189.555,191.796,195.297,199.797,203.793,207.789,210.291,213.288,217.788,224.79,228.786,231.288,234.285,236.787,240.783,243.024,247.524,251.52,254.022,258.018,262.014,264.516,267.018,271.518,276.018,278.259,280.761,285.261" svgx:width="0.5,0.28,0.5,0.25,0.44,0.5,0.33,0.5,0.78,0.44,0.28,0.5,0.5,0.33,0.44,0.5,0.5,0.5,0.25,0.72,0.28,0.28,0.5,0.25,0.28,0.44,0.5,0.5,0.44,0.78,0.25,0.78,0.44,0.39,0.39,0.25,0.39,0.5,0.44,0.44,0.28,0.33,0.5,0.78,0.44,0.28,0.33,0.28,0.44,0.25,0.5,0.44,0.28,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">uid chromatography with tandem mass spectrometric detection to </text>
   <text y="560.051" x="49.605,54.105,58.605,62.601,67.101,69.603,72.105,75.102,79.602,81.852,85.848,89.844,92.841,96.837,99.339,101.841,104.838,107.34,114.342,118.842,123.342,125.592,130.596,137.094,139.344,143.34,146.841,150.342,154.338,157.839,161.34,168.342,172.338,176.838,179.34,182.841" svgx:width="0.5,0.5,0.44,0.5,0.28,0.28,0.33,0.5,0.25,0.44,0.44,0.33,0.44,0.28,0.28,0.33,0.28,0.78,0.5,0.5,0.25,0.56,0.72,0.25,0.44,0.39,0.39,0.44,0.39,0.39,0.78,0.44,0.5,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">quantify ceralifimod PK assessments.</text>
   <text y="571.049" x="49.605,55.923,59.739,63.06,67.884,70.206,73.023,76.344,79.161" svgx:width="0.72,0.44,0.39,0.56,0.28,0.33,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Results: </text>
   <text y="571.049" x="81.213,87.036,90.852,93.669,97.485,99.807,102.129,104.946,107.268,114.09,118.41,122.73,124.782,128.598,132.918,137.238,141.054,144.87,149.19,151.512,154.329,158.145,160.467,162.789,167.109,171.429,174.246,176.568,178.89,185.712,189.528,191.58,195.9,198.717,203.037,205.854,208.176,210.498,214.314,217.635,219.687,223.503,227.823,232.143,234.195,239.019,245.337,247.389,251.709,255.525,258.342,262.158,268.98,272.796,275.118,278.934,281.751,285.252" svgx:width="0.67,0.44,0.33,0.44,0.28,0.28,0.33,0.28,0.78,0.5,0.5,0.25,0.44,0.5,0.5,0.44,0.44,0.5,0.28,0.33,0.44,0.28,0.28,0.5,0.5,0.33,0.28,0.28,0.78,0.44,0.25,0.5,0.33,0.5,0.33,0.28,0.28,0.44,0.39,0.25,0.44,0.5,0.5,0.25,0.56,0.72,0.25,0.5,0.44,0.33,0.44,0.78,0.44,0.28,0.44,0.33,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Ceralifimod concentration-time profiles and PK parameters </text>
   <text y="582.047" x="49.605,52.422,56.238,63.06,66.876,69.198,73.518,77.334,81.654,83.904,84.759,88.575,91.896,95.217,99.033,103.353,105.675,107.997,111.813,114.135,116.457,120.777,123.027,123.882,128.202,132.522,136.338,138.66,140.982,144.798,147.615,151.431,155.751,158.001,158.856,165.174,169.494,173.31,177.63,179.88,180.735,184.551,188.871,192.687,197.007,203.829,206.151,210.471,212.793,216.114,218.436,222.252,225.069,228.885,233.205,235.455,236.31,242.628,244.95,247.272,251.592,253.842,254.697,257.019,259.341,262.158,265.974,269.79,274.11,278.43,282.246" svgx:width="0.33,0.44,0.78,0.44,0.28,0.5,0.44,0.5,0.25,0.55,0.44,0.39,0.39,0.44,0.5,0.28,0.28,0.44,0.28,0.28,0.5,0.25,0.55,0.5,0.5,0.44,0.28,0.28,0.44,0.33,0.44,0.5,0.25,0.55,0.72,0.5,0.44,0.5,0.25,0.55,0.44,0.5,0.44,0.5,0.78,0.28,0.5,0.28,0.39,0.28,0.44,0.33,0.44,0.5,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.28,0.28,0.33,0.44,0.44,0.5,0.5,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">remained essentially unaltered when coadministered with itracona-</text>
   <text y="593.045" x="49.605,53.421,57.741,60.063,63.879,65.949,68.181,73.5,77.82,81.636,84.03,87.351,89.673,93.489,95.811,98.133,101.454,103.776,106.098,109.914,113.73,116.052,118.446,122.262,126.582,130.398,132.72,137.04,140.361,142.683,146.004,148.398,151.215,155.031,158.352,162.672,164.994,167.316,171.132,175.452,177.846,180.168,184.488,186.882,189.204,193.02,196.341,198.663,200.985,203.802,207.618,210.435,214.251,217.068,220.884,225.204,229.02,232.836,235.23,238.047,241.863,244.185,246.507,250.827,253.221,257.037,260.358,262.68,265.002,271.824,275.64,277.962,281.778,285.279" svgx:width="0.44,0.5,0.28,0.44,0.25,0.25,0.61,0.5,0.44,0.25,0.39,0.28,0.44,0.28,0.28,0.39,0.28,0.28,0.44,0.44,0.28,0.25,0.44,0.5,0.44,0.28,0.5,0.39,0.28,0.39,0.25,0.33,0.44,0.39,0.5,0.28,0.28,0.44,0.5,0.25,0.28,0.5,0.25,0.28,0.44,0.39,0.28,0.28,0.33,0.44,0.33,0.44,0.33,0.44,0.5,0.44,0.44,0.25,0.33,0.44,0.28,0.28,0.5,0.25,0.44,0.39,0.28,0.28,0.78,0.44,0.28,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">zole. The statistical analysis resulted in test/reference ratio estimates </text>
   <text y="604.043" x="49.605,52.422,56.742,59.559,62.403,66.723,70.539,74.355,78.675,81.519,85.335,89.655,93.975,97.791,101.607,105.927,108.249,111.066,114.882,117.204,119.526,123.846,128.166,131.01,133.827" svgx:width="0.33,0.5,0.33,0.25,0.5,0.44,0.44,0.5,0.25,0.44,0.5,0.5,0.44,0.44,0.5,0.28,0.33,0.44,0.28,0.28,0.5,0.5,0.25,0.33,0.67" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">for peak concentration (C</text>
   <text y="606.173" x="139.651,144.085,146.566" svgx:width="0.78,0.44,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">max</text>
   <text y="604.103" x="149.374,152.191,155.035,158.851,163.171,167.491,170.335,174.151,176.968,180.784,184.6,187.444,191.764,196.084,200.404,204.22,207.037,209.881,212.203,216.523,220.339,223.183,226.999,231.319,234.136,238.456,242.272,245.116,247.933,254.251,260.569" svgx:width="0.33,0.25,0.44,0.5,0.5,0.25,0.44,0.33,0.44,0.44,0.25,0.5,0.5,0.5,0.44,0.33,0.25,0.28,0.5,0.44,0.25,0.44,0.5,0.33,0.5,0.44,0.25,0.33,0.72,0.72,0.67" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">) and area under the curve (AUC</text>
   <text y="606.173" x="266.392,269.2,271.031,273.839,276.647,279.455" svgx:width="0.5,0.33,0.5,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">0-264h</text>
   <text y="604.103" x="282.263,285.26" svgx:width="0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">) </text>
   <text y="615.101" x="49.604,53.42,55.742,60.062,63.383,67.199,69.449,70.295,72.617,76.937,79.187,80.033,84.353,88.673,92.993,100.31,102.56,103.406,106.223,110.543,114.863,116.933,121.253,128.57,130.82,131.666,135.482,139.802,144.122,146.372,147.218,151.538,155.858,160.178,162.248,166.568,173.885,175.955,178.205,179.051,181.868,185.684,189.005,193.325,197.141,200.957,203.279,205.601,209.921,213.737,216.059,220.379,223.196,225.266,227.516,228.362,232.682,237.002,244.319,246.569,247.415,251.231,255.551,259.871,262.688,265.01,269.33,273.146,277.466,281.282,285.278" svgx:width="0.44,0.28,0.5,0.39,0.44,0.25,0.55,0.28,0.5,0.25,0.55,0.5,0.5,0.5,0.83,0.25,0.55,0.33,0.5,0.5,0.25,0.5,0.83,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.5,0.5,0.5,0.25,0.5,0.83,0.25,0.25,0.55,0.33,0.44,0.39,0.5,0.44,0.44,0.28,0.28,0.5,0.44,0.28,0.5,0.33,0.25,0.25,0.55,0.5,0.5,0.83,0.25,0.55,0.44,0.5,0.5,0.33,0.28,0.5,0.44,0.5,0.44,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">close to 100% (99.7% and 103.5%, respectively). 90% confidence </text>
   <text y="626.099" x="49.604,51.926,56.246,58.568,62.384,65.201,69.521,73.337,75.659,78.98,81.041,85.361,89.177,91.994,94.316,98.636,102.452,106.772,108.833,111.65,114.467,118.787,125.609,127.67,129.992,134.312,138.128,140.189,143.006,146.822,150.143,152.465,156.785,161.105,164.921,167.243,169.304,173.12,175.937,178.754,183.074,185.891,187.952,190.274,194.09,196.907,203.729,205.79,208.607,212.927,217.247,219.317,223.637,226.454,230.774,235.094,239.414,241.484,245.804,253.121,255.182,257.999,262.319,265.136,267.197" svgx:width="0.28,0.5,0.28,0.44,0.33,0.5,0.44,0.28,0.39,0.25,0.5,0.44,0.33,0.28,0.5,0.44,0.5,0.25,0.33,0.33,0.5,0.78,0.25,0.28,0.5,0.44,0.25,0.33,0.44,0.39,0.28,0.5,0.5,0.44,0.28,0.25,0.44,0.33,0.33,0.5,0.33,0.25,0.28,0.44,0.33,0.78,0.25,0.33,0.5,0.5,0.25,0.5,0.33,0.5,0.5,0.5,0.25,0.5,0.83,0.25,0.33,0.5,0.33,0.25,0.67" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">intervals derived from the residual error term (90.9-109.4% for C</text>
   <text y="628.173" x="273.035,277.469,279.95" svgx:width="0.78,0.44,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">max</text>
   <text y="626.103" x="282.758,285.26" svgx:width="0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">; </text>
   <text y="637.101" x="49.604,53.924,58.244,60.314,64.634,67.451,71.438,75.758,80.078,82.148,86.468,93.785,95.54,98.357,102.677,105.494,106.754,113.072,119.39" svgx:width="0.5,0.5,0.25,0.5,0.33,0.5,0.5,0.5,0.25,0.5,0.83,0.25,0.33,0.5,0.33,0.25,0.72,0.72,0.67" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">93.7-114.4% for AUC</text>
   <text y="639.173" x="125.209,128.017,129.848,132.656,135.464,138.272" svgx:width="0.5,0.33,0.5,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">0-264h</text>
   <text y="637.103" x="141.08,143.897,145.652,151.97,155.786,158.603,162.419,164.174,170.492,172.814,175.136,179.456,181.778,186.098,187.853,190.175,194.495,198.311,200.066,204.386,207.707,212.027,215.843,218.165,219.92,222.242,226.562,228.884,232.7,235.517,239.837,243.653,245.975,247.73,250.547,254.867,259.187,262.004,266.324,270.644,274.964,282.281,285.278" svgx:width="0.33,0.25,0.72,0.44,0.33,0.44,0.25,0.72,0.28,0.28,0.5,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.5,0.39,0.5,0.44,0.28,0.25,0.28,0.5,0.28,0.44,0.33,0.5,0.44,0.28,0.25,0.33,0.5,0.5,0.33,0.5,0.5,0.5,0.83,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">) were within the usual interval (80-125%) </text>
   <text y="648.101" x="49.604,52.421,56.741,59.558,61.124,65.444,67.766,72.086,75.902,80.222,84.542,86.864,91.184,95.0,97.322,101.138,105.458,109.274,113.09,114.656,117.977,120.299,124.619,128.939,131.261,135.077,138.398,140.468,142.034,148.352,152.672,156.488,159.305,163.121,165.443,167.765,169.835,171.401,175.721,180.041,181.607,185.423,189.743,194.063,197.879,200.696,204.017,207.833,209.399,213.215,217.535,221.351,225.671,227.993,231.314,232.88,235.697,242.015,247.334,250.655,253.472,255.038,259.358,263.174,266.99,271.31,274.127,276.944,280.76,285.26" svgx:width="0.33,0.5,0.33,0.25,0.5,0.28,0.5,0.44,0.5,0.5,0.28,0.5,0.44,0.28,0.44,0.5,0.44,0.44,0.25,0.39,0.28,0.5,0.5,0.28,0.44,0.39,0.25,0.25,0.72,0.5,0.44,0.33,0.44,0.28,0.28,0.25,0.25,0.5,0.5,0.25,0.44,0.5,0.5,0.44,0.33,0.39,0.44,0.25,0.44,0.5,0.44,0.5,0.28,0.39,0.25,0.33,0.72,0.61,0.39,0.33,0.25,0.5,0.44,0.44,0.5,0.33,0.33,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">for bioequivalence studies. Overall, 14 adverse events (AEs) occurred </text>
   <text y="659.099" x="49.604,51.926,56.246,59.0,63.32,66.074,69.395,73.715,78.035,80.357,84.173,87.989,90.311,93.632,96.386,99.203,103.523,107.843,109.913,114.233,121.55,124.367,126.437,129.191,135.509,137.831,140.153,144.473,147.227,151.547,155.867,158.621,161.438,165.254,167.576,171.392,175.712,179.528,183.848,186.17,188.924,193.244,195.566,198.221,201.038,204.854,207.671,211.487,215.807,219.623,223.439,226.193,228.515,232.835,235.589,237.911,242.231,246.047,248.801,253.121,257.441,264.263,268.583,272.399,275.216,277.97,282.29,285.287" svgx:width="0.28,0.5,0.25,0.5,0.25,0.39,0.5,0.5,0.28,0.44,0.44,0.28,0.39,0.25,0.33,0.5,0.5,0.25,0.5,0.83,0.33,0.25,0.25,0.72,0.28,0.28,0.5,0.25,0.5,0.5,0.25,0.33,0.44,0.28,0.44,0.5,0.44,0.5,0.28,0.25,0.5,0.28,0.33,0.33,0.44,0.33,0.44,0.5,0.44,0.44,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.5,0.5,0.78,0.5,0.44,0.33,0.25,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">in 8 subjects (50.0%), with no relevant difference in the number or </text>
   <text y="670.097" x="49.604,53.924,57.74,60.062,64.382,67.199,71.015,73.085,77.405,80.222,81.797,88.115,93.434,96.755,98.825,103.145,106.961,109.283,115.601,119.417,123.233,127.553,129.623,131.945,136.265,140.081,142.151,144.473,150.791,155.111,157.181,159.503,162.32,166.136,169.952,172.274,179.096,182.912,187.232,189.554,191.624,195.944,199.76,202.577,204.899,209.219,213.539,216.86" svgx:width="0.5,0.44,0.28,0.5,0.33,0.44,0.25,0.5,0.33,0.25,0.72,0.61,0.39,0.25,0.5,0.44,0.28,0.72,0.44,0.44,0.5,0.25,0.28,0.5,0.44,0.25,0.28,0.72,0.5,0.25,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.5,0.44,0.33,0.28,0.5,0.5,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">nature of AEs between the two treatment periods.</text>
   <text y="681.095" x="49.604,56.102,60.602,65.606,69.602,72.104,77.108,80.609,83.111,87.611,92.615,96.116,99.113" svgx:width="0.72,0.5,0.56,0.44,0.28,0.56,0.39,0.28,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Conclusions: </text>
   <text y="681.095" x="102.209,105.206,107.708,110.705,114.701,118.697,123.197,127.697,131.693,135.689,140.189,142.691,146.687,148.937,149.783,154.283,158.783,163.283,165.533,166.379,173.381,177.881,180.383,184.883,188.879,193.379,195.629,196.475,200.975,203.477,207.977,210.227,211.073,215.573,220.073,222.575,224.825,225.671,229.667,232.502,235.499,239.495,243.491,245.993,248.243,249.089,251.591,256.091,260.087,262.337,263.183,268.187,274.685,276.935,277.781,282.281,285.278" svgx:width="0.33,0.28,0.33,0.44,0.44,0.5,0.5,0.44,0.44,0.5,0.28,0.44,0.25,0.55,0.5,0.5,0.5,0.25,0.55,0.78,0.5,0.28,0.5,0.44,0.5,0.25,0.55,0.5,0.28,0.5,0.25,0.55,0.5,0.5,0.28,0.25,0.55,0.44,0.33,0.33,0.44,0.44,0.28,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.56,0.72,0.25,0.55,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Itraconazole 200 mg/day did not affect the PK of </text>
   <text y="692.093" x="49.604,53.6,57.596,60.593,64.589,67.091,69.593,72.59,75.092,82.094,86.594,91.094,93.344,95.639,98.141,102.641,107.141,110.642,112.892,115.187,119.687,124.187,126.482,129.479,133.475,135.977,139.973,144.473,148.469,152.969,155.471,157.766,164.264,170.762,173.759,176.054,182.552,185.054,187.556,192.056,194.351,200.354,206.852,211.856,216.356,222.359,224.654,229.154,232.151,234.446,239.45,243.95,248.45,250.745,253.247,257.747,262.247,264.749,269.249,271.751,274.253,278.753,281.75,285.251" svgx:width="0.44,0.44,0.33,0.44,0.28,0.28,0.33,0.28,0.78,0.5,0.5,0.25,0.25,0.28,0.5,0.5,0.39,0.25,0.25,0.5,0.5,0.25,0.33,0.44,0.28,0.44,0.5,0.44,0.5,0.28,0.25,0.72,0.72,0.33,0.25,0.72,0.28,0.28,0.5,0.25,0.67,0.72,0.56,0.5,0.72,0.25,0.5,0.33,0.25,0.56,0.5,0.5,0.25,0.28,0.5,0.5,0.28,0.5,0.28,0.28,0.5,0.33,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ceralifimod, thus, no relevant DDI with CYP3A or Pgp inhibitors </text>
   <text y="703.091" x="49.604,52.106,55.607,58.325,60.827,65.327,68.045,72.545,76.541,79.259,83.255,87.755,92.255,96.251,100.247,102.749,106.745,111.245,113.495,116.213,122.216,126.212,129.209,133.205,135.707,138.209,141.206,143.708,150.71,155.21,159.71,162.428,166.424,170.42,174.92,177.638,182.138,186.134,188.852,192.848,197.348,201.344,205.844,212.846,215.348,219.848,222.35,225.851,228.353,232.349,235.346,239.342,243.842,246.56,253.058,255.56,258.062,262.562,265.28,269.78,272.777,277.277,281.777,285.278" svgx:width="0.28,0.39,0.25,0.28,0.5,0.25,0.5,0.44,0.25,0.44,0.5,0.5,0.44,0.44,0.28,0.44,0.5,0.25,0.25,0.67,0.44,0.33,0.44,0.28,0.28,0.33,0.28,0.78,0.5,0.5,0.25,0.44,0.44,0.5,0.25,0.5,0.44,0.25,0.44,0.5,0.44,0.5,0.78,0.28,0.5,0.28,0.39,0.28,0.44,0.33,0.44,0.5,0.25,0.72,0.28,0.28,0.5,0.25,0.5,0.33,0.5,0.5,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">is to be expected. Ceralifimod can be coadministered with drugs </text>
   <text y="714.089" x="49.604,54.104,58.604,63.104,69.602,74.102,76.559,79.061,83.561,86.018,88.52,93.02,97.52,100.022,104.522,107.024,109.526,111.983,114.485,118.985,122.981,125.438,131.441,137.939,142.943,147.443,153.446,155.903,158.405,161.906,166.406,170.402,174.902,178.898,183.398,190.4,194.396,196.853,200.849,205.349,209.849,212.351,216.851,219.848,222.305,227.309,231.809,236.309,238.766,245.264,247.766,250.268,254.768,259.268,263.768,266.27,268.727,273.227,277.727,281.228,285.224" svgx:width="0.5,0.5,0.5,0.72,0.5,0.25,0.28,0.5,0.25,0.28,0.5,0.5,0.28,0.5,0.28,0.28,0.25,0.28,0.5,0.44,0.25,0.67,0.72,0.56,0.5,0.72,0.25,0.28,0.39,0.5,0.44,0.5,0.44,0.5,0.78,0.44,0.25,0.44,0.5,0.5,0.28,0.5,0.33,0.25,0.56,0.5,0.5,0.25,0.72,0.28,0.28,0.5,0.5,0.5,0.28,0.25,0.5,0.5,0.39,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">known to inhibit the CYP3A isoenzyme and/or Pgp without dose </text>
   <text y="725.087" x="49.604,53.6,58.1,60.602,65.102,68.603,71.105,78.107,82.103,86.603,89.105" svgx:width="0.44,0.5,0.28,0.5,0.39,0.28,0.78,0.44,0.5,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">adjustment.</text>
  </g>
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:0.44;" d="M297.260 111.160 L350.500 111.160 "/>
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:0.44;" d="M297.260 704.160 L341.490 704.160 "/>
  <g begin="text">
   <text y="76.959" x="297.26,302.759,307.259,311.759" svgx:width="0.61,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">P978</text>
   <text y="87.957" x="297.26,303.758,310.256,314.756,319.256,321.506,329.003,335.501,341.999,348.497,350.747,355.751,360.755,365.255,370.259,373.256,375.758,378.755,381.257,385.253,389.753,392.75,395.252,399.752,404.756,407.006,409.508,417.005,422.009,426.005,430.505,435.005,439.001,442.502,444.752,448.748,451.25,454.247,459.251,463.751,466.253,473.75,478.25,483.254" svgx:width="0.72,0.72,0.5,0.5,0.25,0.83,0.72,0.72,0.72,0.25,0.56,0.56,0.5,0.56,0.33,0.28,0.33,0.28,0.44,0.5,0.33,0.28,0.5,0.56,0.25,0.28,0.83,0.56,0.44,0.5,0.5,0.44,0.39,0.25,0.44,0.28,0.33,0.56,0.5,0.28,0.83,0.5,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">CD19 mRNA quantification improves rituximab </text>
   <text y="98.955" x="297.26,300.257,304.253,308.249,312.749,315.746,323.243,327.239,332.243,335.24,338.237,341.234,345.734,348.731,351.728,356.228,360.224,364.724,368.72,371.717,373.967,378.467,383.471,388.475,392.471,396.971,401.471,405.467,410.471,413.468,415.718,420.218,422.468,427.472,431.468,435.968,440.468,443.465,445.715,450.215,453.212,455.462,459.458,463.958,468.962,472.958,476.954,481.958,484.955,487.205,490.706,493.703,498.707,503.711" svgx:width="0.33,0.44,0.44,0.5,0.33,0.83,0.44,0.56,0.33,0.33,0.33,0.5,0.33,0.33,0.5,0.44,0.5,0.44,0.33,0.25,0.5,0.56,0.56,0.44,0.5,0.5,0.44,0.56,0.33,0.25,0.5,0.25,0.56,0.44,0.5,0.5,0.33,0.25,0.5,0.33,0.25,0.44,0.5,0.56,0.44,0.44,0.56,0.33,0.25,0.39,0.33,0.56,0.56,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">treatment-to-target approach: a proof of concept study</text>
   <text y="109.953" x="297.26,305.261,307.511,313.514,317.51,322.01,326.51,331.01,333.512,337.508,342.008,346.004" svgx:width="0.89,0.25,0.67,0.44,0.5,0.5,0.5,0.28,0.44,0.5,0.44,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">M Capobianco</text>
   <text y="107.439" x="350.503" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="109.959" x="353.428,355.678,357.928,362.932,365.182,373.183,377.179,380.176,384.676,388.672,391.174,393.676" svgx:width="0.25,0.25,0.56,0.25,0.89,0.44,0.33,0.5,0.44,0.28,0.28,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, F Marnetto</text>
   <text y="107.439" x="398.176" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">2</text>
   <text y="109.959" x="401.101,403.351,405.601,411.1,413.35,419.848,422.845,426.841,431.341,433.843,437.839,440.836" svgx:width="0.25,0.25,0.61,0.25,0.72,0.33,0.44,0.5,0.28,0.44,0.33,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, L Granieri</text>
   <text y="107.439" x="443.337" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">2</text>
   <text y="109.959" x="446.262,448.512,450.762,455.766,458.016,464.514,468.51,471.012,475.008,479.508,482.01,484.512,489.012" svgx:width="0.25,0.25,0.56,0.25,0.72,0.44,0.28,0.44,0.5,0.28,0.28,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, P Valentino</text>
   <text y="107.439" x="493.512" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">2</text>
   <text y="109.959" x="496.437,498.687,500.937,508.938" svgx:width="0.25,0.25,0.89,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, M </text>
   <text y="120.957" x="297.258,302.262,306.258,310.758,313.26,317.256,320.757,324.258" svgx:width="0.56,0.44,0.5,0.28,0.44,0.39,0.39,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Pautasso</text>
   <text y="118.439" x="328.759" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">3</text>
   <text y="120.959" x="331.684,333.934,336.184,342.682,344.932,350.935,354.931,357.928,360.43,364.93,367.432,371.932,374.434,376.936" svgx:width="0.25,0.25,0.72,0.25,0.67,0.44,0.33,0.28,0.5,0.28,0.5,0.28,0.28,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, A Bertolotto</text>
   <text y="118.439" x="381.436" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="129.437" x="297.26" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">1</text>
   <text y="131.959" x="300.273,305.907,312.54,319.173,321.558,326.193,328.578,330.963,336.102,340.737,343.374,348.009,350.646,353.031,359.664,364.299,368.934,372.57,377.205,381.84,386.475,388.86,391.245,397.383,400.02,402.657,407.292,409.929,414.06,418.695,421.332,423.717,429.855,433.986,438.621,442.257,446.892,449.529,454.164,458.799,462.93,465.315,467.7,473.334,477.465,482.1,484.737,489.372,494.007,498.642,501.144" svgx:width="0.61,0.72,0.72,0.25,0.5,0.25,0.25,0.56,0.5,0.28,0.5,0.28,0.25,0.72,0.5,0.5,0.39,0.5,0.5,0.5,0.25,0.25,0.67,0.28,0.28,0.5,0.28,0.44,0.5,0.28,0.25,0.67,0.44,0.5,0.39,0.5,0.28,0.5,0.5,0.44,0.25,0.25,0.61,0.44,0.5,0.28,0.5,0.5,0.5,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">AOU S. Luigi Gonzaga, Clinical Neurology, Regional </text>
   <text y="142.957" x="297.258,302.892,307.023,309.66,313.791,317.427,321.063,323.7,328.335,332.97,335.355,342.987,347.622,350.259,352.896,355.533,360.168,362.805,366.936,369.321,373.956,378.087,380.724,384.855,388.491,393.126,396.762,399.399,403.035,405.42,411.558,415.689,420.324,422.961,427.092,430.728,433.113,436.245,442.383,448.017,453.651,458.286,465.918,469.05,471.435,473.82,480.453,484.089,488.724,493.359,496.995,500.631,505.266,509.901,514.536,516.786" svgx:width="0.61,0.44,0.28,0.44,0.39,0.39,0.28,0.5,0.5,0.25,0.83,0.5,0.28,0.28,0.28,0.5,0.28,0.44,0.25,0.5,0.44,0.28,0.44,0.39,0.5,0.39,0.28,0.39,0.25,0.67,0.44,0.5,0.28,0.44,0.39,0.25,0.33,0.67,0.61,0.61,0.5,0.83,0.33,0.25,0.25,0.72,0.39,0.5,0.5,0.39,0.39,0.5,0.5,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Referring Multiple Sclerosis Center (CRESM), Orbassano, </text>
   <text y="153.955" x="297.258,300.39,303.027,307.662,310.299,314.43,316.815" svgx:width="0.33,0.28,0.5,0.28,0.44,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Italy, </text>
   <text y="151.439" x="319.202" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">2</text>
   <text y="153.959" x="322.214,328.352,332.483,337.118,340.754,345.389,349.025,353.156,355.793,359.924,364.559,368.69,372.821,375.206,378.338,382.973,386.609,389.246,391.883,394.52,399.155,401.792,405.923,408.308,414.446,419.081,423.212,427.847,430.484,433.121,437.252,440.888,443.525,445.91,452.543,455.18,457.817,462.452,465.089,469.22,473.855,478.49,483.125,485.762,488.147,491.279,497.417,500.549,506.687,513.32,516.453,518.703" svgx:width="0.67,0.44,0.5,0.39,0.5,0.39,0.44,0.28,0.44,0.5,0.44,0.44,0.25,0.33,0.5,0.39,0.28,0.28,0.28,0.5,0.28,0.44,0.25,0.67,0.5,0.44,0.5,0.28,0.28,0.44,0.39,0.28,0.25,0.72,0.28,0.28,0.5,0.28,0.44,0.5,0.5,0.5,0.28,0.25,0.33,0.67,0.33,0.67,0.72,0.33,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Neuroscience Institute Cavalieri Ottolenghi (NICO), </text>
   <text y="164.957" x="297.257,302.891,309.524,316.157,318.542,323.177,325.562,327.947,333.086,337.721,340.358,344.993,347.63,350.015,356.648,361.283,365.918,369.554,374.189,378.824,383.459,385.844,388.229,394.367,397.004,399.641,404.276,406.913,411.044,415.68,418.316,420.702,426.84,430.971,435.606,439.242,443.877,448.512,451.149,455.784,458.421,463.056,467.691,471.822,474.207,480.84,485.475,488.112,490.749,493.134,495.519,501.153,505.284,509.919,512.556,517.191,521.826,526.461,528.963" svgx:width="0.61,0.72,0.72,0.25,0.5,0.25,0.25,0.56,0.5,0.28,0.5,0.28,0.25,0.72,0.5,0.5,0.39,0.5,0.5,0.5,0.25,0.25,0.67,0.28,0.28,0.5,0.28,0.44,0.5,0.28,0.25,0.67,0.44,0.5,0.39,0.5,0.5,0.28,0.5,0.28,0.5,0.5,0.44,0.25,0.72,0.5,0.28,0.28,0.25,0.25,0.61,0.44,0.5,0.28,0.5,0.5,0.5,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">AOU S. Luigi Gonzaga, Clinical Neurobiology Unit, Regional </text>
   <text y="175.955" x="297.257,302.891,307.022,309.659,313.79,317.426,321.062,323.699,328.334,332.969,335.354,342.986,347.621,350.258,352.895,355.532,360.167,362.804,366.935,369.32,373.955,378.086,380.723,384.854,388.49,393.125,396.761,399.398,403.034,405.419,411.557,415.688,420.323,422.96,427.091,430.727,433.112,436.244,442.382,448.016,453.65,458.285,465.917,469.049,471.434,473.819,480.452,484.088,488.723,493.358,496.994,500.63,505.265,509.9,514.535,516.785" svgx:width="0.61,0.44,0.28,0.44,0.39,0.39,0.28,0.5,0.5,0.25,0.83,0.5,0.28,0.28,0.28,0.5,0.28,0.44,0.25,0.5,0.44,0.28,0.44,0.39,0.5,0.39,0.28,0.39,0.25,0.67,0.44,0.5,0.28,0.44,0.39,0.25,0.33,0.67,0.61,0.61,0.5,0.83,0.33,0.25,0.25,0.72,0.39,0.5,0.5,0.39,0.39,0.5,0.5,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Referring Multiple Sclerosis Center (CRESM), Orbassano, </text>
   <text y="186.953" x="297.257,300.389,303.026,307.661,310.298,314.429,316.814" svgx:width="0.33,0.28,0.5,0.28,0.44,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Italy, </text>
   <text y="184.439" x="319.202" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">3</text>
   <text y="186.959" x="322.214,327.848,334.481,341.114,343.499,348.134,350.519,352.904,358.043,362.678,365.315,369.95,372.587,374.972,381.605,386.24,390.875,394.511,399.146,403.781,408.416,410.801,413.186,419.324,421.961,424.598,429.233,431.87,436.001,440.637,443.273,445.659,451.293,455.928,458.565,463.2,467.835,470.472,475.107,479.742,483.873,486.258,492.891,497.526,500.163,502.8,505.05" svgx:width="0.61,0.72,0.72,0.25,0.5,0.25,0.25,0.56,0.5,0.28,0.5,0.28,0.25,0.72,0.5,0.5,0.39,0.5,0.5,0.5,0.25,0.25,0.67,0.28,0.28,0.5,0.28,0.44,0.5,0.28,0.25,0.61,0.5,0.28,0.5,0.5,0.28,0.5,0.5,0.44,0.25,0.72,0.5,0.28,0.28,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">AOU S. Luigi Gonzaga, Clinical Pathology Unit, </text>
   <text y="197.957" x="297.257,302.396,307.031,311.666,316.301,319.937,324.572,327.209,331.844,335.48,339.611,341.996,346.631,349.268,351.653,357.791,360.428,363.065,367.7,370.337,374.468,379.103,381.74,384.125,388.76,393.395,398.03,400.415,408.047,410.684,414.815,418.451,423.086,427.721,430.358,434.993,437.63,442.266,446.901,449.538,453.669,458.304,460.941,463.326,468.96,473.595,478.23,480.867,484.998,488.634,492.765,496.401,498.651" svgx:width="0.56,0.5,0.5,0.5,0.39,0.5,0.28,0.5,0.39,0.44,0.25,0.5,0.28,0.25,0.67,0.28,0.28,0.5,0.28,0.44,0.5,0.28,0.25,0.5,0.5,0.5,0.25,0.83,0.28,0.44,0.39,0.5,0.5,0.28,0.5,0.28,0.5,0.5,0.28,0.44,0.5,0.28,0.25,0.61,0.5,0.5,0.28,0.44,0.39,0.44,0.39,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Laboratory of Clinical and Microbiological Analyses, </text>
   <text y="208.955" x="297.257,303.89,307.526,312.161,316.796,320.432,324.068,328.703,333.338,337.973,340.358,342.743,345.875,348.512,353.147,355.784" svgx:width="0.72,0.39,0.5,0.5,0.39,0.39,0.5,0.5,0.5,0.25,0.25,0.33,0.28,0.5,0.28,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Orbassano, Italy</text>
   <text y="235.955" x="297.257,303.26,307.76,311.756,316.76,321.26,325.094,329.594,334.598,339.602,344.606,347.603" svgx:width="0.67,0.5,0.44,0.56,0.5,0.44,0.5,0.56,0.56,0.56,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Background: </text>
   <text y="235.955" x="350.942,356.945,359.447,361.949,366.449,370.949,373.451,380.453,384.449,388.949,391.199,392.288,395.285,400.748,406.247,412.745,415.742,417.992,419.081,421.583,425.084,427.334,428.423,432.419,434.669,435.758,439.754,444.254,446.756,453.758,457.754,460.751,463.253,467.249,469.499,470.588,477.59,482.09,486.59,491.09,495.086,497.588,502.088,506.588,510.584,513.086,515.336,516.425,520.421,524.921,527.423,529.925" svgx:width="0.67,0.28,0.28,0.5,0.5,0.28,0.78,0.44,0.5,0.25,0.55,0.33,0.67,0.61,0.72,0.33,0.25,0.55,0.28,0.39,0.25,0.55,0.44,0.25,0.55,0.44,0.5,0.28,0.78,0.44,0.33,0.28,0.44,0.25,0.55,0.78,0.5,0.5,0.5,0.44,0.28,0.5,0.5,0.44,0.28,0.25,0.55,0.44,0.5,0.28,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Rituximab (RTX) is a chimeric monoclonal anti-</text>
   <text y="246.953" x="297.257,301.757,306.257,310.757,315.257,317.507,318.776,323.276,325.778,328.775,332.771,336.767,339.269,343.265,347.765,350.015,351.284,355.28,359.78,363.776,366.278,370.778,374.279,376.781,379.031,380.301,386.303,392.801,397.301,401.801,404.051,406.301,407.57,411.566,413.816,415.086,421.089,424.086,428.082,432.078,434.58,437.082,439.332,440.601,444.102,448.602,451.599,454.596,458.592,462.588,466.584,468.834,470.103,474.099,478.599,481.101,483.603,488.103,492.099,496.599,498.849,501.099,502.368,506.868,510.369,514.365,518.865,521.115,522.384,525.381,529.881,532.878" svgx:width="0.5,0.5,0.5,0.5,0.25,0.55,0.5,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.55,0.44,0.5,0.44,0.28,0.5,0.39,0.28,0.25,0.55,0.67,0.72,0.5,0.5,0.25,0.25,0.55,0.44,0.25,0.55,0.67,0.33,0.44,0.44,0.28,0.28,0.25,0.55,0.39,0.5,0.33,0.33,0.44,0.44,0.44,0.25,0.55,0.44,0.5,0.28,0.28,0.5,0.44,0.5,0.25,0.25,0.55,0.5,0.39,0.44,0.5,0.25,0.55,0.33,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">body directed against CD20, a B-cell surface antigen, used for </text>
   <text y="257.951" x="297.257,299.759,302.756,306.752,310.748,313.25,320.252,324.248,328.748,331.25,333.5,334.283,338.783,341.78,344.03,344.813,349.313,353.813,358.313,361.31,367.808,372.308,376.808,381.308,385.808,388.31,392.81,395.312,398.813,401.063,401.846,404.348,408.848,415.85,420.35,424.85,429.35,436.353,440.349,442.599,443.382,447.378,451.878,456.378,458.628,459.41,462.911,466.908,471.408,475.404,478.401,482.397,484.899,487.149,487.932,491.928,496.428,498.93,503.43,505.932,512.934,519.936,524.436,528.936,532.932" svgx:width="0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.5,0.5,0.33,0.72,0.5,0.5,0.5,0.5,0.28,0.5,0.33,0.39,0.25,0.55,0.28,0.5,0.78,0.5,0.5,0.5,0.78,0.44,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.39,0.44,0.5,0.44,0.33,0.44,0.28,0.25,0.55,0.44,0.5,0.28,0.5,0.28,0.78,0.78,0.5,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">treatment of non-Hodgkin’s lymphoma and several autoimmune </text>
   <text y="268.949" x="297.257,301.757,304.259,307.76,311.756,315.752,319.253,323.249,326.75,329.0,330.917,333.419,337.919,341.915,344.417,348.917,353.417,355.919,360.419,364.919,366.836,371.336,375.332,382.334,386.834,390.83,393.332,395.835,400.335,404.331,406.833,409.335,413.835,418.335,420.252,424.752,427.254,430.755,434.751,438.747,442.248,446.244,449.745,451.662,456.162,459.159,461.076,463.578,468.078,472.074,473.991,479.994,483.99,488.49,490.992,493.989,497.985,500.487,502.404,508.902,512.898,515.895,520.395,524.895,529.395,532.896" svgx:width="0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.39,0.25,0.25,0.28,0.5,0.44,0.28,0.5,0.5,0.28,0.5,0.5,0.25,0.5,0.44,0.78,0.5,0.44,0.28,0.28,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.39,0.25,0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.67,0.44,0.5,0.28,0.33,0.44,0.28,0.25,0.72,0.44,0.33,0.5,0.5,0.5,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">diseases, including demyelinating diseases of the Central Nervous </text>
   <text y="279.947" x="297.257,302.261,306.761,310.262,312.764,316.76,323.762,326.012,327.497,330.494,336.497,342.995,347.999,350.996,353.246,354.731,358.232,362.732,366.728,371.228,373.478,374.963,378.959,382.46,384.71,386.195,392.198,396.194,398.696,402.692,407.192,410.693,413.195,417.695,422.195,424.445,425.93,431.933,435.929,442.931,445.433,447.935,450.437,452.939,457.439,461.939,464.189,465.674,473.675,478.175,480.677,483.179,485.681,490.181,492.684,496.68,498.93,500.414,505.418,509.414,511.917,515.912,518.909,523.409,526.91,529.412,532.913" svgx:width="0.56,0.5,0.39,0.28,0.44,0.78,0.25,0.55,0.33,0.67,0.72,0.56,0.33,0.25,0.55,0.39,0.5,0.44,0.5,0.25,0.55,0.44,0.39,0.25,0.55,0.67,0.44,0.28,0.44,0.5,0.39,0.28,0.5,0.5,0.25,0.55,0.67,0.44,0.78,0.28,0.28,0.28,0.28,0.5,0.5,0.25,0.55,0.89,0.5,0.28,0.28,0.28,0.5,0.28,0.44,0.25,0.55,0.56,0.44,0.28,0.44,0.33,0.5,0.39,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">System (CNS) such as Relapsing Remitting Multiple Sclerosis </text>
   <text y="290.945" x="297.257,300.254,306.257,312.26,320.261,325.265,328.262,330.512,337.595,341.591,346.091,350.591,352.841,359.924,366.422,370.418,374.918,377.915,382.415,389.417,393.917,397.913,400.415,402.917,405.419,407.921,411.422,413.672,420.755,427.253,431.753,434.255,436.758,440.754,444.75,447.0,454.083,459.087,463.587,467.583,471.579,474.081,477.078,481.578,488.58,490.83,497.913,504.411,506.913,510.414,514.914,517.911,522.411,526.407,529.404,532.905" svgx:width="0.33,0.67,0.67,0.89,0.56,0.33,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.72,0.44,0.5,0.33,0.5,0.78,0.5,0.44,0.28,0.28,0.28,0.28,0.39,0.25,0.55,0.72,0.5,0.28,0.28,0.44,0.44,0.25,0.55,0.56,0.5,0.44,0.44,0.28,0.33,0.5,0.78,0.25,0.55,0.72,0.28,0.39,0.5,0.33,0.5,0.44,0.33,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(RRMS) and Neuromyelitis Optica Spectrum Disorders </text>
   <text y="301.943" x="297.257,300.254,306.752,314.753,321.251,326.255,332.753,336.254,339.251,341.501,343.364,349.862,354.362,356.864,359.366,366.368,368.87,372.371,374.873,379.373,383.873,385.736,388.238,392.738,396.734,398.597,403.097,407.597,411.098,413.6,418.1,422.6,424.464,428.46,432.96,437.46,439.323,446.325,450.825,455.325,457.827,460.329,464.829,467.826,470.328,474.828,479.328,481.191,483.693,488.193,492.189,494.052,497.049,501.045,505.545,508.047,515.049,519.045,523.545,525.408,529.908,532.905" svgx:width="0.33,0.72,0.89,0.72,0.56,0.72,0.39,0.33,0.25,0.25,0.72,0.5,0.28,0.28,0.78,0.28,0.39,0.28,0.5,0.5,0.25,0.28,0.5,0.44,0.25,0.5,0.5,0.39,0.28,0.5,0.5,0.25,0.44,0.5,0.5,0.25,0.78,0.5,0.5,0.28,0.28,0.5,0.33,0.28,0.5,0.5,0.25,0.28,0.5,0.44,0.25,0.33,0.44,0.5,0.28,0.78,0.44,0.5,0.25,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(NMOSDs). Optimising the dosing and monitoring the regimen of </text>
   <text y="312.941" x="297.257,302.72,308.219,314.717,316.967,318.875,321.377,324.374,328.37,332.366,334.868,341.87,345.866,350.366,352.868,355.118,357.026,359.528,363.029,365.279,367.187,371.183,375.683,377.933,379.841,384.341,387.176,391.676,395.672,400.172,402.674,404.924,406.832,410.828,415.328,419.324,421.826,424.328,428.324,432.824,437.324,441.32,443.57,445.478,448.475,452.975,455.972,458.222,460.13,462.632,467.132,471.128,473.378,475.286,482.288,486.284,490.784,494.78,499.28,503.276,510.279,514.274,518.774,521.276,523.526,525.435,529.935,532.932" svgx:width="0.67,0.61,0.72,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.55,0.28,0.39,0.25,0.55,0.44,0.5,0.25,0.55,0.5,0.33,0.5,0.44,0.5,0.28,0.25,0.55,0.44,0.5,0.44,0.28,0.28,0.44,0.5,0.5,0.44,0.25,0.55,0.33,0.5,0.33,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.78,0.44,0.5,0.44,0.5,0.44,0.78,0.44,0.5,0.28,0.25,0.55,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">RTX treatment is an urgent challenge for the management of </text>
   <text y="323.939" x="297.257,301.757,305.753,308.255,310.757,314.753,319.253,321.755,325.256,327.074,333.572,336.074,338.576,343.076,344.894,347.891,351.887,354.389,358.385,362.885,366.386,368.888,373.388,377.888,379.706,383.702,388.202,390.704,395.204,397.707,404.709,411.711,416.211,420.711,424.707,426.525,431.025,433.527,437.028,441.528,444.525,449.025,453.021,456.018,459.519,461.337,465.837,468.834,470.652,476.655,483.153,488.157,490.407,492.063,497.562,502.062,504.564,508.065,509.883,516.885,520.881,524.877,529.377,532.878" svgx:width="0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.72,0.28,0.28,0.5,0.25,0.33,0.44,0.28,0.44,0.5,0.39,0.28,0.5,0.5,0.25,0.44,0.5,0.28,0.5,0.28,0.78,0.78,0.5,0.5,0.44,0.25,0.5,0.28,0.39,0.5,0.33,0.5,0.44,0.33,0.39,0.25,0.5,0.33,0.25,0.67,0.72,0.56,0.25,0.25,0.61,0.5,0.28,0.39,0.25,0.78,0.44,0.44,0.5,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">patients with relapsing autoimmune disorders of CNS. This means </text>
   <text y="334.937" x="297.257,304.259,308.255,312.755,315.257,322.259,324.761,328.757,331.259,335.759,340.259,342.437,344.939,349.439,353.435,355.613,359.609,362.445,365.442,367.944,371.94,375.936,379.932,384.432,386.61,391.11,394.107,396.285,398.787,403.287,407.283,409.461,414.924,420.423,426.921,429.099,431.601,434.598,438.594,442.59,445.092,452.094,456.09,460.59,463.092,465.27,469.266,473.766,478.266,480.444,483.441,487.437,491.937,496.437,500.433,502.935,507.435,511.935,514.113,518.613,523.113,527.109,529.916" svgx:width="0.78,0.44,0.5,0.28,0.78,0.28,0.44,0.28,0.5,0.5,0.25,0.28,0.5,0.44,0.25,0.44,0.33,0.33,0.28,0.44,0.44,0.44,0.5,0.25,0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.67,0.61,0.72,0.25,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.44,0.5,0.5,0.25,0.33,0.44,0.5,0.5,0.44,0.28,0.5,0.5,0.25,0.5,0.5,0.44,0.33,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">maximizing the efficacy of the RTX treatment and reducing over-</text>
   <text y="345.935" x="297.257,299.759,302.756,306.752,310.748,313.25,320.252,324.248,328.748,331.25,333.5,335.75,338.801,342.797,347.297,351.797,354.047,357.098,359.6,364.1,368.096,370.346,373.397,377.393,381.893,385.394,387.896,390.146,393.197,397.193,401.693,406.193,408.443,411.494,414.491,416.993,420.495,424.995,428.496,430.746,433.797,438.297,441.294,443.544,446.595,450.096,454.092,458.592,462.588,465.585,469.581,471.831,474.882,478.878,483.378,487.878,491.874,494.871,498.372,502.368,504.618,507.669,511.665,516.165,520.161,524.661,527.163,530.664,532.914" svgx:width="0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.44,0.5,0.39,0.28,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.33,0.28,0.39,0.5,0.39,0.25,0.55,0.5,0.33,0.25,0.55,0.39,0.44,0.5,0.44,0.33,0.44,0.25,0.55,0.44,0.5,0.5,0.44,0.33,0.39,0.44,0.25,0.55,0.44,0.5,0.44,0.5,0.28,0.39,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">treatment, and the cost and risks of severe adverse events. </text>
   <text y="356.933" x="297.257,305.258,309.758,314.258,316.76,319.262,323.762,326.759,329.261,333.761,338.261,340.763,345.263,347.765,352.265,356.765,361.265,363.767,369.77,376.268,380.768,385.268,390.344,392.846,398.849,401.351,405.347,409.343,411.845,414.347,417.848,420.35,424.85,429.35,431.852,436.856,439.358,443.858,450.356,452.858,458.861,463.361,465.863,470.363,477.365,481.361,483.863,486.86,491.36,493.862,496.859,501.863,507.866,510.863,513.365,515.867,519.368,521.87,524.372,528.872,532.868" svgx:width="0.89,0.5,0.5,0.28,0.28,0.5,0.33,0.28,0.5,0.5,0.25,0.5,0.28,0.5,0.5,0.5,0.25,0.67,0.72,0.5,0.5,0.56,0.25,0.67,0.25,0.44,0.44,0.28,0.28,0.39,0.25,0.5,0.5,0.25,0.56,0.28,0.5,0.72,0.25,0.67,0.5,0.28,0.5,0.78,0.44,0.28,0.33,0.5,0.25,0.33,0.56,0.67,0.33,0.25,0.28,0.39,0.25,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Monitoring blood CD19+ B cells by Flow Cytometry (FC) is the </text>
   <text y="367.931" x="297.257,301.253,305.753,312.755,319.757,324.257,328.757,331.016,334.517,337.019,340.016,344.012,346.514,350.51,355.01,359.51,361.769,364.271,368.771,371.03,375.53,379.526,382.523,386.025,390.525,395.025,399.021,401.523,404.025,408.021,412.017,414.276,419.739,425.238,431.736,433.995,436.992,440.988,443.985,446.487,449.484,453.48,457.476,459.978,466.98,470.976,475.476,477.978,480.237,483.234,488.418,491.415,495.411,499.407,501.909,508.911,512.907,517.407,519.909,522.906,525.408,529.908" svgx:width="0.44,0.5,0.78,0.78,0.5,0.5,0.25,0.39,0.28,0.33,0.44,0.28,0.44,0.5,0.5,0.25,0.28,0.5,0.25,0.5,0.44,0.33,0.39,0.5,0.5,0.44,0.28,0.28,0.44,0.44,0.25,0.67,0.61,0.72,0.25,0.33,0.44,0.33,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.33,0.61,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.33,0.28,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">common strategy to personalize RTX re-treatment (Treatment-to-</text>
   <text y="378.929" x="297.257,299.759,303.755,306.59,311.09,315.086,317.588,320.585,324.581,329.081,333.581,336.578,341.078,345.074,349.07,353.57,356.567,358.817,360.545,365.045,369.545,372.047,373.784,376.781,380.777,383.28,387.276,391.776,395.277,399.273,402.774,404.502,409.002,412.998,416.994,421.494,424.491,426.228,430.728,434.724,438.225,442.725,445.227,447.729,451.725,453.453,459.456,465.954,470.454,474.954,476.691,480.687,485.187,487.689,490.191,494.691,498.687,503.187,504.915,507.912,511.908,518.91,522.906,525.408,529.908" svgx:width="0.28,0.44,0.33,0.5,0.44,0.28,0.33,0.44,0.5,0.5,0.33,0.5,0.44,0.44,0.5,0.33,0.25,0.25,0.5,0.5,0.28,0.25,0.33,0.44,0.28,0.44,0.5,0.39,0.44,0.39,0.25,0.5,0.44,0.44,0.5,0.33,0.25,0.5,0.44,0.39,0.5,0.28,0.28,0.44,0.25,0.67,0.72,0.5,0.5,0.25,0.44,0.5,0.28,0.28,0.5,0.44,0.5,0.25,0.33,0.44,0.78,0.44,0.28,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">target-approach), but relapses occur despite CD19 antigen remain-</text>
   <text y="389.927" x="297.257,299.759,304.259,308.759,311.216,315.716,320.216,324.716,328.712,331.709,334.166,336.668,341.168,345.164,347.621,350.123,354.623,357.62,361.616,365.117,369.617,374.117,376.619,381.119,383.576,386.573,391.649,394.106,398.606,400.856,405.356,412.853,415.31,417.813,422.313,424.815,428.811,431.313,433.77,436.272,440.772,447.774,452.274,456.774,461.274,465.27,469.77,472.272,476.268,479.769,482.766,485.016,487.473,491.973,496.473,499.974,503.475,505.977,510.477,512.979,517.479,519.936,524.436,528.936,532.932" svgx:width="0.28,0.5,0.5,0.25,0.5,0.5,0.5,0.44,0.33,0.25,0.28,0.5,0.44,0.25,0.28,0.5,0.33,0.44,0.39,0.5,0.5,0.28,0.5,0.25,0.33,0.56,0.25,0.5,0.25,0.5,0.83,0.25,0.28,0.5,0.28,0.44,0.28,0.25,0.28,0.5,0.78,0.5,0.5,0.5,0.44,0.5,0.28,0.44,0.39,0.33,0.25,0.25,0.5,0.5,0.39,0.39,0.28,0.5,0.28,0.5,0.25,0.5,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ing under the threshold (&lt; 0.1% total lymphocytes), possibly due </text>
   <text y="400.925" x="297.257,299.759,304.259,306.509,310.505,312.755,315.257,317.759,324.761,327.263,329.765,333.761,338.261,340.511,344.012,348.008,352.508,356.009,358.512,361.014,363.516,368.016,370.518,373.02,377.52,379.77,384.27,387.267,389.517,394.521,400.524" svgx:width="0.28,0.5,0.25,0.44,0.25,0.28,0.28,0.78,0.28,0.28,0.44,0.5,0.25,0.39,0.44,0.5,0.39,0.28,0.28,0.28,0.5,0.28,0.28,0.5,0.25,0.5,0.33,0.25,0.56,0.67,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">to a limited sensitivity of FC.</text>
   <text y="411.923" x="297.257,304.259,309.263,312.26,316.256,320.252,323.249,325.751,330.251,334.247,337.748,340.745" svgx:width="0.78,0.56,0.33,0.44,0.44,0.33,0.28,0.5,0.44,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Objectives: </text>
   <text y="411.923" x="342.599,349.097,351.599,358.601,360.455,364.955,367.952,369.806,372.308,376.808,380.804,382.658,387.158,390.155,394.151,397.652,401.648,406.148,408.65,410.504,414.005,416.508,421.008,425.508,430.008,431.862,434.364,437.865,439.719,442.221,446.721,448.575,452.571,457.071,464.073,468.573,472.569,475.566,479.562,481.416,485.916,488.913,492.909,495.906,499.902,506.904,511.404,513.906,516.408,519.405,521.907,525.903,529.899" svgx:width="0.72,0.28,0.78,0.25,0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.5,0.33,0.44,0.39,0.44,0.5,0.28,0.25,0.39,0.28,0.5,0.5,0.5,0.25,0.28,0.39,0.25,0.28,0.5,0.25,0.44,0.5,0.78,0.5,0.44,0.33,0.44,0.25,0.5,0.33,0.44,0.33,0.44,0.78,0.5,0.28,0.28,0.33,0.28,0.44,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Aim of the present study is to compare pre-amplifica-</text>
   <text y="422.921" x="297.257,299.759,302.261,306.761,311.261,313.295,316.292,320.468,326.966,329.963,331.997,338.0,341.996,345.992,348.494,350.366,355.55,358.052,365.054,369.05,371.084,376.088,382.091,388.094,390.128,393.125,398.588,403.259,406.256,411.26,417.263,423.266,426.263,428.297,432.797,435.299,439.799,444.299,448.799,450.833,456.836,463.334,467.834,472.334,474.368,481.37,487.373,493.871,499.874,501.908,506.408,510.908,514.904,519.404,521.906,524.408,527.405,529.907" svgx:width="0.28,0.28,0.5,0.5,0.25,0.33,0.56,0.72,0.33,0.25,0.67,0.44,0.44,0.28,0.25,0.61,0.28,0.78,0.44,0.25,0.56,0.67,0.67,0.25,0.33,0.67,0.61,0.33,0.56,0.67,0.67,0.33,0.25,0.5,0.28,0.5,0.5,0.5,0.25,0.67,0.72,0.5,0.5,0.25,0.78,0.67,0.72,0.72,0.25,0.5,0.5,0.44,0.5,0.28,0.28,0.33,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">tion (PA) Real Time PCR (RT-PCR) blood CD19 mRNA quantifi-</text>
   <text y="433.919" x="297.257,301.253,305.249,307.751,310.253,314.753,319.253,321.503,328.001,330.503,333.005,337.505,339.755,344.759,350.762" svgx:width="0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.72,0.28,0.28,0.5,0.25,0.56,0.67,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">cation with FC.</text>
   <text y="444.917" x="297.257,305.753,309.749,312.746,317.75,322.25,327.254,330.755,333.752" svgx:width="0.94,0.44,0.33,0.56,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Methods: </text>
   <text y="444.917" x="336.326,341.33,343.832,348.332,352.328,354.902,358.403,362.399,365.396,367.898,371.894,375.395,377.969,382.469,385.466,388.04,392.54,395.042,399.542,404.042,408.542,411.116,414.617,418.613,425.616,430.116,432.618,436.614,440.115,442.689,445.686,448.683,453.183,460.185,462.759,467.259,469.833,476.331,484.332,490.83,495.834,502.332,504.906,509.406,513.402,515.904,518.406,522.402,526.902,529.404,532.905" svgx:width="0.56,0.28,0.5,0.44,0.25,0.39,0.44,0.33,0.28,0.44,0.39,0.25,0.5,0.33,0.25,0.5,0.28,0.5,0.5,0.5,0.25,0.39,0.44,0.78,0.5,0.28,0.44,0.39,0.25,0.33,0.33,0.5,0.78,0.25,0.5,0.25,0.72,0.89,0.72,0.56,0.72,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Five series of blood samples from 3 NMOSD patients </text>
   <text y="455.915" x="297.257,299.759,302.756,306.752,310.748,313.25,317.246,321.746,323.996,325.868,332.366,334.868,337.37,341.87,344.12,345.992,351.455,356.954,363.452,365.702,367.574,374.072,378.068,381.065,385.061,387.311,389.183,392.684,395.186,399.686,404.186,406.688,410.684,415.184,417.434,419.306,422.303,426.803,431.303,433.553,435.426,439.926,442.428,446.928,451.428,455.928,458.178,460.05,463.551,467.547,474.549,479.049,481.551,485.547,489.048,492.045,494.295,496.545,498.417,502.413,506.913,510.909,513.411,517.911,521.412,523.914,528.414,532.914" svgx:width="0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.67,0.61,0.72,0.25,0.55,0.72,0.44,0.33,0.44,0.25,0.55,0.39,0.28,0.5,0.5,0.28,0.44,0.5,0.25,0.55,0.33,0.5,0.5,0.25,0.55,0.5,0.28,0.5,0.5,0.5,0.25,0.55,0.39,0.44,0.78,0.5,0.28,0.44,0.39,0.33,0.25,0.25,0.55,0.44,0.5,0.44,0.28,0.5,0.39,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">treated with RTX were studied (47 blood samples), analysing </text>
   <text y="466.913" x="297.257,303.26,309.758,314.258,318.758,323.834,326.363,332.366,334.895,338.891,342.887,345.389,347.891,351.392,353.921,358.421,362.921,365.45,370.454,376.457,378.986,382.982,387.482,391.982,394.511,398.687,405.185,408.182,413.645,418.316,421.313,426.317,432.32,438.323,440.825,443.354,447.35,449.879,454.379,458.879,462.38,464.882,467.384,469.886,474.386,476.888,479.39,483.89,486.419,488.921,493.421,496.418,500.414,503.915,508.415,512.915,515.417,519.917,522.446,525.443,529.943,532.94" svgx:width="0.67,0.72,0.5,0.5,0.56,0.25,0.67,0.25,0.44,0.44,0.28,0.28,0.39,0.25,0.5,0.5,0.25,0.56,0.67,0.25,0.44,0.5,0.5,0.25,0.56,0.72,0.33,0.67,0.61,0.33,0.56,0.67,0.67,0.28,0.25,0.44,0.25,0.5,0.5,0.39,0.28,0.28,0.28,0.5,0.28,0.28,0.5,0.25,0.28,0.5,0.33,0.44,0.39,0.5,0.5,0.28,0.5,0.25,0.33,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">CD19+ B cells by FC and PA-RT-PCR; a positivity threshold for </text>
   <text y="477.911" x="297.257,301.433,307.931,310.928,316.391,321.062,324.059,329.063,335.066,341.069,343.319,344.75,351.248,355.244,358.745,360.995,362.426,366.926,370.922,373.919,376.421,380.921,384.917,389.417,391.667,393.098,396.095,402.098,408.596,413.096,417.596,419.846,421.277,428.279,434.282,440.78,446.783,449.033,450.464,456.467,460.463,462.965,466.961,469.463,471.965,476.465,480.461,482.711,484.142,489.641,494.141,498.641,501.638,505.634,509.135,512.636,515.138,519.638,524.138,526.388,527.819,532.895" svgx:width="0.56,0.72,0.33,0.67,0.61,0.33,0.56,0.67,0.67,0.25,0.55,0.72,0.44,0.39,0.25,0.55,0.5,0.44,0.33,0.28,0.5,0.44,0.5,0.25,0.55,0.33,0.67,0.72,0.5,0.5,0.25,0.55,0.78,0.67,0.72,0.72,0.25,0.55,0.67,0.44,0.28,0.44,0.28,0.28,0.5,0.44,0.25,0.55,0.61,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.25,0.55,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">PA-RT-PCR was defined (CD19 mRNA Relative Expression &gt; </text>
   <text y="488.909" x="297.257,301.757,304.007,308.507,313.007,317.507,322.007,326.507" svgx:width="0.5,0.25,0.5,0.5,0.5,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">1,739x10</text>
   <text y="486.439" x="331.01,332.958" svgx:width="0.33,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">-3</text>
   <text y="488.959" x="335.883,338.88" svgx:width="0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">).</text>
   <text y="499.957" x="297.264,303.762,307.758,311.259,316.263,318.765,321.762,325.263,328.26" svgx:width="0.72,0.44,0.39,0.56,0.28,0.33,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Results: </text>
   <text y="499.957" x="330.636,336.639,343.137,347.637,352.137,357.213,359.589,365.592,367.968,371.964,375.96,378.462,380.964,384.465,386.841,393.339,397.335,400.332,404.328,406.704,411.204,415.704,419.7,424.2,426.702,429.204,432.201,434.703,438.699,443.199,445.575,450.075,454.575,456.951,461.127,467.625,470.622,476.085,480.756,483.753,488.757,494.76,500.763,503.139,505.641,510.141,512.517,516.513,519.015,521.517,523.893,528.393,532.893" svgx:width="0.67,0.72,0.5,0.5,0.56,0.25,0.67,0.25,0.44,0.44,0.28,0.28,0.39,0.25,0.72,0.44,0.33,0.44,0.25,0.5,0.5,0.44,0.5,0.28,0.28,0.33,0.28,0.44,0.5,0.25,0.5,0.5,0.25,0.56,0.72,0.33,0.67,0.61,0.33,0.56,0.67,0.67,0.25,0.28,0.5,0.25,0.44,0.28,0.28,0.25,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">CD19+ B cells were quantified by PA-RT-PCR in all 47 </text>
   <text y="510.955" x="297.264,300.765,304.761,311.763,316.263,318.765,322.761,326.262,328.512,330.627,337.125,341.625,345.621,348.618,352.614,356.61,360.111,362.217,364.719,369.219,373.215,377.715,379.83,386.328,390.324,393.321,397.317,399.423,404.499,406.614,411.114,413.364,417.864,425.361,427.476,431.976,434.973,437.088,439.59,444.09,446.592,450.588,453.09,455.205,457.707,462.207,469.209,473.709,478.209,482.709,486.705,491.205,493.707,497.703,501.204,503.31,505.812,510.312,512.427,516.927,521.427,523.929,528.429,532.929" svgx:width="0.39,0.44,0.78,0.5,0.28,0.44,0.39,0.25,0.25,0.72,0.5,0.44,0.33,0.44,0.44,0.39,0.25,0.28,0.5,0.44,0.5,0.25,0.72,0.44,0.33,0.44,0.25,0.56,0.25,0.5,0.25,0.5,0.83,0.25,0.5,0.33,0.25,0.28,0.5,0.28,0.44,0.28,0.25,0.28,0.5,0.78,0.5,0.5,0.5,0.44,0.5,0.28,0.44,0.39,0.25,0.28,0.5,0.25,0.5,0.5,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">samples, whereas they were &lt; 0.1% of total lymphocytes in 31/47 </text>
   <text y="521.953" x="297.264,300.765,304.761,311.763,316.263,318.765,322.761,326.262,328.926,332.922,337.422,341.418,343.92,348.42,351.921,355.917,360.417,363.081,367.581,372.081,374.745,379.749,385.752,388.002,390.666,393.663,398.163,400.827,404.823,407.325,409.827,412.491,415.992,419.988,426.99,431.49,433.992,437.988,441.489,444.153,446.655,451.155,453.819,460.317,464.817,467.319,471.315,475.815,478.479,484.482,490.98,495.48,499.98,505.056,507.72,513.723,516.387,520.383,524.379,526.881,529.383,532.884" svgx:width="0.39,0.44,0.78,0.5,0.28,0.44,0.39,0.25,0.44,0.5,0.44,0.28,0.5,0.39,0.44,0.5,0.25,0.5,0.5,0.25,0.56,0.67,0.25,0.25,0.33,0.5,0.25,0.44,0.28,0.28,0.25,0.39,0.44,0.78,0.5,0.28,0.44,0.39,0.25,0.28,0.5,0.25,0.72,0.5,0.28,0.44,0.5,0.25,0.67,0.72,0.5,0.5,0.56,0.25,0.67,0.25,0.44,0.44,0.28,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">samples analysed by FC. In all samples in which CD19+ B cells </text>
   <text y="532.951" x="297.264,303.762,307.758,310.755,314.751,316.695,320.691,325.191,329.691,334.191,338.187,340.131,345.135,351.138,353.082,355.584,360.084,363.081,367.077,370.578,375.078,379.578,382.08,386.58,388.83,390.774,396.777,403.275,407.775,412.275,414.219,421.221,427.224,433.722,439.725,441.669,448.167,452.163,455.664,457.608,461.604,464.106,467.607,472.107,474.051,478.047,482.547,487.047,491.547,495.543,497.487,499.989,502.491,505.992,507.936,510.438,514.938,517.935,521.931,525.432,529.932" svgx:width="0.72,0.44,0.33,0.44,0.25,0.44,0.5,0.5,0.5,0.44,0.25,0.56,0.67,0.25,0.28,0.5,0.33,0.44,0.39,0.5,0.5,0.28,0.5,0.25,0.25,0.67,0.72,0.5,0.5,0.25,0.78,0.67,0.72,0.72,0.25,0.72,0.44,0.39,0.25,0.44,0.28,0.39,0.5,0.25,0.44,0.5,0.5,0.5,0.44,0.25,0.28,0.28,0.39,0.25,0.28,0.5,0.33,0.44,0.39,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">were above FC threshold, CD19 mRNA was also above its thresh-</text>
   <text y="543.949" x="297.264,301.764,304.266,308.766,311.016,313.266,315.867,318.864,323.364,325.866,329.862,332.859,336.855,340.356,342.858,345.36,349.86,354.36,356.862,360.777,363.027,365.277,367.878,373.881,380.379,384.879,389.379,391.629,394.23,401.232,407.235,413.733,419.736,421.986,424.587,431.085,435.081,438.582,440.832,443.433,447.429,449.931,453.432,457.932,460.182,462.783,466.779,471.279,475.779,480.279,484.275,486.525,489.126,493.302,499.8,502.797,508.26,512.931,515.928,520.932,526.935,532.938" svgx:width="0.5,0.28,0.5,0.25,0.25,0.55,0.33,0.5,0.28,0.44,0.33,0.44,0.39,0.28,0.28,0.5,0.5,0.28,0.5,0.25,0.25,0.55,0.67,0.72,0.5,0.5,0.25,0.55,0.78,0.67,0.72,0.72,0.25,0.55,0.72,0.44,0.39,0.25,0.55,0.44,0.28,0.39,0.5,0.25,0.55,0.44,0.5,0.5,0.5,0.44,0.25,0.55,0.56,0.72,0.33,0.67,0.61,0.33,0.56,0.67,0.67,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">old. Interestingly, CD19 mRNA was also above PA-RT-PCR </text>
   <text y="554.947" x="297.264,299.766,304.266,307.263,311.259,314.76,319.26,323.76,326.262,330.762,333.012,333.921,336.423,340.923,343.173,344.082,348.582,350.832,351.741,356.241,358.743,363.243,367.239,370.236,372.486,373.395,377.895,381.891,384.393,387.39,391.386,395.886,398.136,399.045,402.546,406.542,413.544,418.044,420.546,424.542,428.043,430.293,432.543,433.452,439.95,444.45,446.952,450.948,455.448,457.698,458.607,461.604,465.6,469.101,473.601,476.103,478.605,482.601,487.101,489.351,490.26,494.76,498.756,503.256,507.252,509.754,512.256,516.756,520.752,523.002,523.911,528.411,532.911" svgx:width="0.28,0.5,0.33,0.44,0.39,0.5,0.5,0.28,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.5,0.25,0.55,0.5,0.28,0.5,0.44,0.33,0.25,0.55,0.5,0.44,0.28,0.33,0.44,0.5,0.25,0.55,0.39,0.44,0.78,0.5,0.28,0.44,0.39,0.25,0.25,0.55,0.72,0.5,0.28,0.44,0.5,0.25,0.55,0.33,0.44,0.39,0.5,0.28,0.28,0.44,0.5,0.25,0.55,0.5,0.44,0.5,0.44,0.28,0.28,0.5,0.44,0.25,0.55,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">threshold in 8 other paired samples, which resulted negative by </text>
   <text y="565.945" x="297.264,302.268,308.271,310.521,313.149,317.145,321.645,326.145,328.773,333.273,336.27,340.266,344.262,348.258,352.758,356.754,361.254,363.882,366.384,370.884,374.88,377.508,382.008,386.508,390.009,392.511,395.013,397.515,402.015,404.517,407.019,411.519,414.147,418.647,421.644,424.272,429.276,435.279,437.907,440.409,444.909,447.537,452.037,454.665,459.165,463.665,466.167,468.795,473.295,475.923,480.423,483.42,486.048,488.55,493.05,497.046,504.048,506.676,511.176,515.676,518.304,522.804,525.432,528.429,532.929" svgx:width="0.56,0.67,0.25,0.25,0.44,0.5,0.5,0.25,0.5,0.33,0.44,0.44,0.44,0.5,0.44,0.5,0.25,0.28,0.5,0.44,0.25,0.5,0.5,0.39,0.28,0.28,0.28,0.5,0.28,0.28,0.5,0.25,0.5,0.33,0.25,0.56,0.67,0.25,0.28,0.5,0.25,0.5,0.25,0.5,0.5,0.28,0.25,0.5,0.25,0.5,0.33,0.25,0.28,0.5,0.44,0.78,0.25,0.5,0.5,0.25,0.5,0.25,0.33,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">FC, and preceded the positivity of FC in 7 out 8 of them by 1 -3 </text>
   <text y="576.943" x="297.264,304.266,308.766,313.266,315.768,320.268,323.769" svgx:width="0.78,0.5,0.5,0.28,0.5,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">months.</text>
   <text y="587.941" x="297.264,303.762,308.262,313.266,317.262,319.764,324.768,328.269,330.771,335.271,340.275,343.776,346.773" svgx:width="0.72,0.5,0.56,0.44,0.28,0.56,0.39,0.28,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Conclusions: </text>
   <text y="587.941" x="350.535,356.034,360.534,364.53,366.78,368.292,372.792,375.789,379.785,383.286,387.282,391.782,394.284,396.534,398.046,401.547,404.049,408.549,413.049,417.549,419.799,421.311,423.813,428.313,432.813,435.315,439.311,443.307,445.809,449.805,453.306,455.556,457.068,459.57,464.07,468.066,470.568,472.818,474.33,476.832,481.332,485.328,487.578,489.09,493.266,499.764,502.761,508.224,512.895,515.892,520.896,526.899,532.902" svgx:width="0.61,0.5,0.44,0.25,0.55,0.5,0.33,0.44,0.39,0.44,0.5,0.28,0.25,0.55,0.39,0.28,0.5,0.5,0.5,0.25,0.55,0.28,0.5,0.5,0.28,0.44,0.44,0.28,0.44,0.39,0.25,0.55,0.28,0.5,0.44,0.28,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.56,0.72,0.33,0.67,0.61,0.33,0.56,0.67,0.67,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">The present study indicates that the PA-RT-PCR </text>
   <text y="598.939" x="297.264,304.266,308.262,310.764,315.264,319.764,324.264,326.784,330.78,335.28,339.78,342.282,346.782,349.302,353.802,357.798,360.318,364.314,366.834,373.836,378.336,381.333,385.329,387.849,391.35,395.346,399.846,403.347,405.849,408.351,410.853,415.353,419.349,421.869,425.37,427.872,430.869,434.865,437.367,441.363,445.863,450.363,452.883,455.385,459.885,463.881,468.381,470.901,475.905,481.908,484.428,487.425,491.925,494.922,497.442,499.944,504.444,508.44,510.96,515.46,519.456,521.958,525.954,529.95" svgx:width="0.78,0.44,0.28,0.5,0.5,0.5,0.25,0.44,0.5,0.5,0.28,0.5,0.25,0.5,0.44,0.25,0.44,0.25,0.78,0.5,0.33,0.44,0.25,0.39,0.44,0.5,0.39,0.28,0.28,0.28,0.5,0.44,0.25,0.39,0.28,0.33,0.44,0.28,0.44,0.5,0.5,0.25,0.28,0.5,0.44,0.5,0.25,0.56,0.67,0.25,0.33,0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.5,0.44,0.28,0.44,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">method could be a more sensitive strategy than FC for the detec-</text>
   <text y="609.937" x="297.264,299.766,302.268,306.768,311.268,313.518,315.264,319.764,322.761,325.011,326.757,332.76,339.258,343.758,348.258,353.334,355.584,357.33,363.333,365.583,367.329,371.325,375.321,377.823,380.325,383.826,386.076,388.326,390.072,392.574,397.074,401.574,405.075,407.325,409.071,411.573,418.575,423.075,426.072,430.572,435.072,437.574,442.074,446.574,448.824,450.57,453.072,457.572,461.568,463.818,465.564,468.066,471.063,475.059,479.055,481.557,488.559,492.555,497.055,499.557,502.554,505.056,509.556,512.553,515.055,519.051,521.886,526.386,530.382,532.884" svgx:width="0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.67,0.72,0.5,0.5,0.56,0.25,0.55,0.67,0.25,0.55,0.44,0.44,0.28,0.28,0.39,0.25,0.25,0.55,0.28,0.5,0.5,0.39,0.25,0.55,0.28,0.78,0.5,0.33,0.5,0.5,0.28,0.5,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.33,0.28,0.5,0.33,0.28,0.44,0.33,0.5,0.44,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">tion of CD19+ B cells, thus improving the treatment-to-target </text>
   <text y="620.935" x="297.264,301.26,305.76,310.26,313.257,317.757,321.753,325.749,330.249,332.877,337.377,340.374,343.002,348.465,353.964,360.462,363.09,366.087,370.083,372.585,375.582,379.578,383.574,386.076,393.078,397.074,401.574,404.076,406.326,408.792,414.291,418.791,421.293,424.794,427.422,431.418,435.918,440.418,443.415,447.915,451.911,455.907,460.407,463.035,467.031,471.531,476.031,478.533,483.033,485.661,490.161,494.157,496.785,500.781,505.281,509.781,512.283,514.785,518.781,523.281,525.909,528.411,532.911" svgx:width="0.44,0.5,0.5,0.33,0.5,0.44,0.44,0.5,0.25,0.5,0.33,0.25,0.67,0.61,0.72,0.25,0.33,0.44,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.25,0.61,0.5,0.28,0.39,0.25,0.44,0.5,0.5,0.33,0.5,0.44,0.44,0.5,0.25,0.44,0.5,0.5,0.28,0.5,0.25,0.5,0.44,0.25,0.44,0.5,0.5,0.28,0.28,0.44,0.5,0.25,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">approach of RTX retreatment. This approach could be applied to </text>
   <text y="631.933" x="297.264,301.764,304.266,308.766,312.762,315.759,318.009,318.846,324.309,329.808,336.306,339.303,341.553,342.39,344.892,347.889,351.885,355.881,358.383,362.379,366.879,369.129,369.966,374.466,376.968,380.469,384.465,388.461,391.962,395.958,399.459,401.709,402.546,406.542,411.042,415.542,417.792,418.629,421.131,425.631,427.881,428.718,433.218,435.72,440.22,444.216,447.213,449.463,450.3,457.302,461.802,466.302,470.802,474.798,477.3,481.8,486.3,490.296,492.798,495.048,495.885,499.881,504.381,506.883,509.385,513.885,518.385,522.885,525.387,529.383,532.884" svgx:width="0.5,0.28,0.5,0.44,0.33,0.25,0.55,0.67,0.61,0.72,0.33,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.55,0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.39,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.5,0.28,0.5,0.44,0.33,0.25,0.55,0.78,0.5,0.5,0.5,0.44,0.28,0.5,0.5,0.44,0.28,0.25,0.55,0.44,0.5,0.28,0.28,0.5,0.5,0.5,0.28,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">other RTX- treated diseases and to other monoclonal antibodies </text>
   <text y="642.931" x="297.264,301.764,304.266,307.263,311.259,315.255,317.757,321.753,326.253,328.503,332.499,336.999,340.995,343.497,347.997,351.498,354.0,356.25,362.253,368.751,373.251,377.751,382.827,385.077,391.08,393.33,397.326,401.322,403.824,406.326,409.827" svgx:width="0.5,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.44,0.5,0.44,0.28,0.5,0.39,0.28,0.25,0.67,0.72,0.5,0.5,0.56,0.25,0.67,0.25,0.44,0.44,0.28,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">directed against CD20+ B cells.</text>
   <text y="669.931" x="297.264,302.763,307.263,311.763" svgx:width="0.61,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">P979</text>
   <text y="680.929" x="297.264,302.763,306.759,310.755,313.257,318.261,323.265,327.261,331.257,335.757,338.259,340.509,345.513,348.015,352.515,357.015,362.019,364.269,366.771,371.271,378.768,383.772,388.776,393.276,397.272,401.772,404.769,408.765,411.015,415.011,419.511,424.515,429.519,432.516,435.513,437.763,442.263,444.513,449.517,454.017,457.518,461.019,463.521,468.525,471.027,475.023" svgx:width="0.61,0.44,0.44,0.28,0.56,0.56,0.44,0.44,0.5,0.28,0.25,0.56,0.28,0.5,0.5,0.56,0.25,0.28,0.5,0.83,0.56,0.56,0.5,0.44,0.5,0.33,0.44,0.25,0.44,0.5,0.56,0.56,0.33,0.33,0.25,0.5,0.25,0.56,0.5,0.39,0.39,0.28,0.56,0.28,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Peripheral blood lymphocyte count: a possible </text>
   <text y="691.927" x="297.264,299.766,307.263,314.76,319.764,324.768,329.268,331.77,336.27,340.77,343.272,347.268,351.768,354.27,356.52,364.017,368.517,372.513,377.517,381.513,385.509,387.759,392.259,395.256,397.506,400.503,403.005,408.009,412.509,417.009,419.511,422.013,429.51,434.01,439.014,441.264,445.26,448.257,451.254,453.756,457.752,462.252,466.248,470.748" svgx:width="0.28,0.83,0.83,0.56,0.56,0.5,0.28,0.5,0.5,0.28,0.44,0.5,0.28,0.25,0.83,0.5,0.44,0.56,0.44,0.44,0.25,0.5,0.33,0.25,0.33,0.28,0.56,0.5,0.5,0.28,0.28,0.83,0.5,0.56,0.25,0.44,0.33,0.33,0.28,0.44,0.5,0.44,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">immunological marker of fingolimod efficacy?</text>
   <text y="702.925" x="297.264,305.265,307.515,313.014,317.01,320.007,323.004,327.0,329.997,334.497,338.997" svgx:width="0.89,0.25,0.61,0.44,0.33,0.33,0.44,0.33,0.5,0.5,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">M Zaffaroni</text>
   <text y="700.439" x="341.494" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="702.959" x="344.419,346.669,348.919,355.417,357.667,363.67,367.666,370.663,375.163,379.663,383.659,386.161,390.661" svgx:width="0.25,0.25,0.72,0.25,0.67,0.44,0.33,0.5,0.5,0.44,0.28,0.5,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, D Baroncini</text>
   <text y="700.439" x="393.163" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="702.959" x="396.088,398.338,400.588,407.086,409.336,415.339,417.841,421.837,426.337,430.333,434.833" svgx:width="0.25,0.25,0.72,0.25,0.67,0.28,0.44,0.5,0.44,0.5,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, A Bianchi</text>
   <text y="700.439" x="437.334" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="702.959" x="440.259,442.509,444.759,449.763,452.013,458.511,463.011,467.511,472.011,476.511,480.507,484.503,488.499" svgx:width="0.25,0.25,0.56,0.25,0.72,0.5,0.5,0.5,0.5,0.44,0.44,0.44,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, P Annovazzi</text>
   <text y="700.439" x="491.001" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="702.959" x="493.926,496.176,498.426,503.43,511.431" svgx:width="0.25,0.25,0.56,0.89,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, SM </text>
   <text y="713.957" x="297.258,303.261,307.257,309.759,314.259,316.761,321.261" svgx:width="0.67,0.44,0.28,0.5,0.28,0.5,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Baldini</text>
   <text y="711.439" x="323.765" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="713.959" x="326.69,328.94,331.19,337.688,339.938,347.939,350.441,354.941,359.441,363.941,367.937,370.439" svgx:width="0.25,0.25,0.72,0.25,0.89,0.28,0.5,0.5,0.5,0.44,0.28,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, G Minonzio</text>
   <text y="711.439" x="374.938" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">2</text>
   <text y="713.959" x="377.863,380.113,382.363,388.861,391.111,397.609,402.109,406.105,410.101,414.097" svgx:width="0.25,0.25,0.72,0.25,0.72,0.5,0.44,0.44,0.44,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, A Ghezzi</text>
   <text y="711.439" x="416.599" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="713.959" x="419.524,421.774,424.024,430.522,432.772,438.775,443.275,450.277" svgx:width="0.25,0.25,0.72,0.25,0.67,0.5,0.78,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, G Comi</text>
   <text y="711.439" x="452.778" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">3</text>
   <text y="722.437" x="297.262" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">1</text>
   <text y="724.959" x="300.185,307.682,312.182,314.684,317.186,319.688,324.188,326.69,330.686,332.936,337.436,341.432,343.934,347.93,351.431,355.931,359.432,361.934,365.435,367.685,372.185,374.687,379.187,383.687,387.683,389.933,395.936,399.932,404.432,406.934,410.435,414.431,416.681,418.931,423.431,425.681,427.931,433.43,437.93,440.432,444.932,449.432,451.934,456.434,458.684,464.183,468.683,473.183,475.685,479.681,481.931,488.429,492.929,496.43,500.93,503.432,505.934,510.434,512.936,515.186" svgx:width="0.83,0.5,0.28,0.28,0.28,0.5,0.28,0.44,0.25,0.5,0.44,0.28,0.44,0.39,0.5,0.39,0.28,0.39,0.25,0.5,0.28,0.5,0.5,0.44,0.25,0.67,0.44,0.5,0.28,0.39,0.44,0.25,0.25,0.5,0.25,0.25,0.61,0.5,0.28,0.5,0.5,0.28,0.5,0.25,0.61,0.5,0.5,0.28,0.44,0.25,0.72,0.5,0.39,0.5,0.28,0.28,0.5,0.28,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Multiple Sclerosis Study Centre, S. Antonio Abate Hospital, </text>
  </g>
 </g>
</svg>
